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ABSTRACT
This dissertation reviews the pathomechanics of plantar ulceration in 
patients with diabetes mellitus, and studies the relationship between 
joint mobility, pressure and the location of ulceration at the first 
metatarsal head.
Neuropathy, mechanical stress and vascular disease have been shown to be 
the primary causes of ulceration in patients with diabetes. Sensory 
neuropathy is considered the permissive cause of plantar ulceration. 
Plantar ulcerations do not occur without loss of sensation in the foot. 
Other factors including motor neuropathy, autonomic neuropathy, abnormal 
mechanical stress, foot deformity, joint limitation, and hyperkeratosis 
are considered important component causes in plantar ulceration. 
Autonomic neuropathy and vascular disease are trophic factors which 
cause tissues to be more susceptible to damage and ulceration, but are 
not direct causes. Motor neuropathy, foot deformity, joint limitation 
and hyperkeratosis are associated with high foot pressures. Individuals 
with high foot pressures and loss of protective sensation develop 
ulcerations from repeated injuries during walking.
Plantar ulcerations commonly occur at the first metatarsal head. This 
study was conducted to determine if first ray joint limitation was 
related to ulceration at the first metatarsal head. Measurements of 
first ray mobility, pressure, and other physical measurements were made 
on 19 diabetic patients with a history of ulceration at the first
metatarsal head, 20 diabetic patients with a history of ulceration at 
other locations of the forefoot, 19 matched diabetic, and 19 matched 
non-diabetic controls.
Analysis of variance showed patients with a history of first metatarsal 
head ulceration had significantly lower first ray mobility and 
significantly higher pressure at the first metatarsal head compared to 
the other groups. Regression analysis showed a strong, negative, linear 
relationship between limited dorsiflexion of the first ray, and peak 
pressure and the pressure-time integral.
Analysis of other physical measurements showed duration of diabetes was 
signicantly higher, and sensation, range of motion at the hip, ankle and 
foot was significantly lower in patients with a history of ulceration 
compared to controls.
The results demonstrate that the pathomechanical factors, limited joint 
mobility and high pressure, are significantly related to plantar 
ulceration and ulcer location in diabetes.
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CHAPTER 1
THE PATHOMECHANICS OF PLANTAR ULCERATION IN DIABETES MELLITUS:
A LITERATURE REVIEW
1.1. INTRODUCTION
Foot ulceration in patients with diabetes mellitus is a major public 
health concern in the United States. In 1990, the Center for Disease 
Control estimated there were 14 million people in the United States 
affected by diabetes of whom 25% are expected to develop foot 
problems.28 Foot problems account for 20% of the annual diabetic 
related hospitalizations,53 and over 50% of the 120,000 non-traumatic 
lower extremity amputations each year result from complications of 
diabetes.63
Foot ulcerations develop from a combination of causes rather than a 
single cause (Figure 1.1).15 Neuropathy, mechanical stresses, and 
angiopathy (vascular disease) are considered the major causes of foot 
ulcers in diabetic patients, but a number of other factors have also 
been cited.1’9’11,17’36’70 Neuropathy, as compared to angiopathy, has been 
shown to be a much more important factor in foot ulceration than 
previously believed.12,15’35’52’56’75 There is strong cross-sectional and 
prospective data to show neuropathy and abnormal mechanical stresses are 
the primary cause of ulcerations on the bottom of the foot (plantar 
ulceration). 11,59,78 A purely vascular pathogenesis accounts for only 7 - 

































Figure 1.1. Causes of ulceration. Modified from A.J.M. Boulton, 1992.
non-plantar in location.75 In a recent study neuropathy was also found 
to be a more common pathway than angiopathy in lower extremity 
amputation.63
1.2. NEUROPATHY: A PERMISSIVE ROLE IN PLANTAR ULCERATION
Neuropathy is considered a necessary factor in the sequela of plantar 
ulceration formation. This section reviews the permissive role of 
neuropathy in injury to the foot, and describes the characteristics of 
neuropathic ulceration.
Altered nerve metabolism, resulting from chronic hyperglycemia, is the 
likely cause of polyneuropathy in diabetes.14 The prevalence of diabetic 
neuropathy has been shown to be higher in diabetic patients with poorly 
controlled glucose.64 A distal, mixed sensory-motor-autonomic neuropathy 
is most common, involving both the large and small diameter fibers. 
There is a predominance of sensory over motor involvement.43 Loss of 
pain and temperature sensation predisposes the area of involvement to 
repeated injuries from burns and mechanical stresses. Distal motor 
neuropathy results in weakness of the intrinsic muscles of the foot 
which leads to the development of claw toe and cavus foot deformities. 
Muscle atrophy decreases the soft tissue padding of the foot. Weakness 
of extrinsic peroneal innervated muscles contributes to equinovarus 
deformities. These deformities cause an abnormal weight-bearing 
distribution.36
The foot of a diabetic patient does not spontaneously ulcerate. Loss of 
sensation is an essential factor in plantar ulceration, and without 
insensitivity in the foot ulceration is uncommon.11,15,63 Brand was the 
first to describe this important concept, in the development of plantar 
ulceration in leprosy and diabetes, based on observation data.16 Boulton 
et al. found diabetic patients with plantar ulceration had significantly 
decreased vibratory sensation and increased plantar pressures compared 
to diabetic patients without ulceration, or normal controls.11
Several studies have measured vibratory, pressure and thermal sensory 
thresholds in the feet of patients with a history of plantar ulceration 
to determine the threshold level at which injuries occur. The sensory 
thresholds, in these studies, have been referred to as the level of loss 
of protective sensation.6,10,47,60,71 While studies have not agreed on a 
precise sensory level for protective sensation, the concept appears to 
be a valuable clinical decision making tool for preventative care 
programs.7,45
The contribution of autonomic neuropathy on foot ulceration has not been 
well studied, but may be a factor in both ulceration and faulty healing 
of ulcers. Nielubowicz et al. in studies on dogs found paw ulceration 
occured only if both sympathetic and somatic nerves were transected.62 
They concluded that sympathectomy causes the opening of arteriovenious 
anastomoses in the extremity which results in peripheral ischemia, 
venostasis, and nutritional changes in the tissues. Manley and Darby 
found that denervated rat pads subjected to repeated stresses ulcerated
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at a faster rate than their non-denervated controls.58 This study would 
support the view that neuropathy produces trophic effects which 
contribute to tissue breakdown.
In humans, sympathetic denervation has been shown to result in dilation 
of the arteries and arterioles increasing blood flow to the 
foot.3’34'35’37 This is associated with arteriovenous shunting which 
rushes blood from the arterial to venous side of circulation, but by­
passing the capillary nutrient circulation. Long-term sympathetic 
denervation may cause structural changes in the artery and lead to 
medial wall calcification. Reduced capillary flow may increase tissue 
susceptibility to injury, slow tissue healing, and reduce tissue 
resistance to infection.79 Additionally autonomic neuropathy reduces 
sweat gland function which may contribute to tissue breakdown by the 
drying and cracking of skin.16’36
Young et al. found the relationship between somatic neuropathy and 
autonomic neuropathy in diabetes was not uniform.80 Diabetic patients 
with ulceration had a similar degree of autonomic neuropathy, but had 
higher somatic neuropathy compared to patients with no history of 
ulceration. They concluded that it was unlikely that autonomic 
neuropathy was of prime pathogenic importance in foot ulceration.
The dilation and shunting of vessels increases the blood supply to the 
bones of the foot. Bone scan studies with radiopharmaceutical agents 
show increased uptake proportional to increased blood flow and
osteoblastic activity in neuropathic patients compared to non-diabetic 
controls.19’35 Accelerated osteoblastic activity results in 
demineralization and predisposes the bones to damage and deformity 
(Charcot osteoarthropathy) by minor trauma. Charcot deformity is a 
severe and relatively common deformity in diabetics that has been 
associated with midfoot ulceration.6,61
1.2.1. Characteristics of Neuropathic Ulcers
Neuropathic ulcers are described as painless, round, surrounded by 
callus, and located over prominent bony areas of the toes or plantar 
surface of the foot.31 A single lesion is more common than multiple 
lesions. The most common site of ulceration in the diabetic patient is 
the first metatarsal head.29 The foot is warm, dry, and pink. The 
patient is initally unaware of the lesion and may only notice it by the 
presence of blood or pus. Loss of sensation is an essential predisposing 
factor accompanied by mechanical, thermal or chemical injury.16,31,36 In 
contrast, ulcerations due to poor circulation have been characterized as 
painful, irregular shaped, without callus, non-plantar, and multifocal.
In summary neuropathy is a primary component in the pathomechanics of 
plantar ulceration. Somatic neuropathy results in loss of protective 
sensation which permits injuries to the foot to take place. Atrophy and 
deformity in the foot, due to muscle weakness, alter the weightbearing 
distribution which contributes to foot injuries. Autonomic neuropathy 
causes drying and cracking of skin which may be a factor in tissue
breakdown. Loss of sympathetic vasomotor control promotes dilated 
arteries, arteriovenous shunting, and abnormal capillary flow which may 
increase the risk of tissue breakdown, infection, impaired healing, and 
Charcot deformity. Studies strongly support the conclusion that sensory 
loss is the primary or permissive cause of plantar ulceration.
1.3. MECHANICAL STRESS AND ULCERATION
This section reviews the relationship of mechanical stress and plantar 
ulceration, the mechanism of injury to the diabetic foot and methodology 
in measurement of pressure. Mechanical stress is the most common direct 
cause of injury in the neuropathic foot. Stresses usually occur at the 
interface of the foot with the ground or a shoe.
1.3.1. Mechanisms of Injury
Brand described four mechanisms of injury in the neuropathic foot: 
ischemia, direct trauma, repetitive stress and infection.16 Ischemia 
occurs when blood flow to the tissues is blocked by pressures as low as
1 - 5  psi ( 7 - 3 5  KPa) over long periods of time. Ischemic injury is
most commonly caused by wearing tight shoes. Koziak, in a study on 16 
dogs, showed a pressure-time relationship between ischemia and 
ulceration.54 Pressures as low as 20 KPa cause ulceration if 
continuously applied for a long enough duration (12 hours). Ulceration 
also occurred when higher pressures were applied for shorter periods of 
time. Low pressure intermittently applied did not cause ulceration.
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Patients who change their shoes frequently may protect themselves from 
ischemic ulcers.
Direct trauma results from a single high pressure greater than 6,900 KPa 
and only occurs if a patient walks barefoot on a sharp object, or if a 
nail penetrates a shoe.16 Patients who never walk barefoot are greatly 
protected from direct trauma ulceration. Brand observed the most common 
cause of injury to the neuopathic foot is repetitive stress. Moderate 
pressures (about 138 KPa) repeated thousands of times a day may cause 
ulceration.16 In two separate studies on denervated rat foot pads, 
repetitive moderate pressure resulted in inflammation, autolysis, and 
finally ulceration over a 7-10 day period.4'58 Brand theorized that the 
human foot is subjected to similar repetitive stresses during walking.
A person with normal sensation may develop inflammation from repetitive 
walking stresses but pain causes him to remove the source of irritation, 
change the way he walks, or stop the activity. The person with loss of 
protective sensation, however, continues to walk in the same manner 
unaware of impending injury.
1.3.2. Abnormal Pressure and Plantar Ulceration
Brand suggested that relatively normal pressures on the foot could cause 
injury to the neuropathic foot.16,17 Several studies, however, have shown 
that plantar ulcerations occur at the sites of highest pressure and that 
these loads are significantly higher in ulcerated compared to non­
ulcerated feet. Stokes et al. measured loads under the feet of diabetic
and non-diabetics subjects using a force plate.73 Maximal loading was 
increased in diabetic patients with ulcers compared to those without 
ulcers, and non-diabetic subjects. The position of maximal loading 
corresponded to the site of ulceration, and greater than normal loading 
was found at areas of callus formation. Diabetic patients with ulcers 
had decreased loading on the toes compared to normals. No differences 
were found in force due to age or gender, but there was an association 
between body weight and loading.
Ctercteko et al. studied forces on the feet of diabetic patients with 
ulceration, those with neuropathy but no ulceration, and normal subjects 
while walking on a load sensitive platform.29 Their findings supported 
those of Stokes et al. Toe loading was found to be lower in diabetic 
patients compared to normals, and the site of maximum force was found 
under the site of ulceration. They found foot deformity was a common 
feature in patients with areas of increased loading. Ulcerated patients 
were found to be heavier than non-ulcerated subjects.
Rogers, using the Penn State University piezoelectric pressure platform, 
studied the relationship of body weight, height, foot width, foot 
length, first ray mobility, arch index (a measurement of arch height), 
percent body fat and age on foot pressure in 60 normal male subjects.65 
She found weight, arch index, and height were the significant predictors 
for regional pressure.
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Cavanagh et al., using a pressure platform, also found the site of 
ulceration in diabetic patients corresponded to the location of highest 
pressure on the foot, and found reduced toe loading in diabetic 
patients.23 They determined that structural deformities in the foot 
resulted in areas of abnormally high pressure, and recommended that 
pressure assessment be part of routine foot screening in the early 
stages of diabetes to identify the foot at risk.
High foot pressure may not only be a consequence of diabetes but may 
also be a pre-existing condition. Cavanagh found in studies on "normal 
feet" that some non-syptomatic, non-diabetic individuals have high foot 
pressure.24 They determined the variation of pressure in the foot was so 
wide that the use of the mean + 2 standard deviations places patients at 
risk for ulceration in the range of "normality".
Significantly high foot pressures have been found in diabetic patients 
with neuropathy compared to diabetics without neuropathy and their non­
diabetic controls.13,77 Abnormal pressure was associated with a decreased 
toe loading ratio which was suggestive of neuropathy related foot 
deformity. Veves et al., in a prospective study of 80 patients, found 
pressure increased over a 2 year period compared to controls. The 
authors believe high pressure in the diabetic foot results from 
deformity associated with a progressive motor neuropathy.
In summary, there is convincing data that mechanical stress (abnormal 
pressure) is related to plantar ulceration. Studies have shown that body
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weight, height, foot deformity, and neuropathy may be sources of high 
pressure in diabetics. Interpretation of these studies is confounded by 
the interrelationship of the measured variables with pressure.
1.3.3. Measurement of Foot Pressure
Pressure, or more correctly vertical stress, is the force per unit area. 
Shear stress or horozontal stress is the angular measurement of force 
per unit area.74 Vertical stresses on the foot have higher magnitudes 
but shear stresses may be more important in the causation of tissue 
injury and ulceration. No satisfactory method is available to measure 
shear. There are three approaches to pressure measurement: 1) barefoot 
to ground, 2) shoe to ground, and 3) foot to shoe insole.24,57 Barefoot 
to ground measurements are most valuable for understanding the function 
of the normal and abnormal foot, while shoe-ground and foot-insole 
measures are more valuable for studying the effect of footwear on the 
foot. In diabetes barefoot studies may be used to identify the foot at 
risk, and demonstrate structural foot changes over time. Inshoe 
measurements are subject to inaccuracies due to imprecise positioning of 
sensors under the anatomical areas of interest. The limitation due to 
sensor size, may result in measurement error over bony prominences. 
Sensors average pressure over their area of measurement and are very 
sensitive to the placement.24
There are basicly two types of pressure devices 1) discrete tranducers 
and 2) pressure plates or mats.23,57 Discrete transducers measure
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pressure from a limited number of locations where the sensors are 
placed, and therefore suffer greatest from inaccuracies due to 
positioning. Pressure plates and mats measure across the entire sole.
The resolution of pressure plates/mats is dependent on the number of the 
sensors arrayed within the device. There are three major commercially 
available plate/mat systems: the Optical Pedobarograph (Biokinetics, 
Bethesda, MD), the EMED system (Novel TJSA, Minneapolis, MN), and the 
FSCAN device (Tekscan, Inc., Boston, MA). The Pedobarograph uses a mat 
with tiny dimples overlying a plate of glass illuminated at its edges by 
a light. The illumination of light is distorted proportionally by 
pressure during walking, and a video camera records the signal which is 
digitized and calibrated. A color printout is produced which displays 
peak pressure for a single walk. The EMED system consists of a platform 
with capacitance transducers (2 transducers per square cm). An inshoe 
mat is also available for the EMED System. The FSCAN is only available 
in an inshoe mat. It utilizes a thin disposable mat (0.004 inch thick) 
with an array of 950 capacitive sensors.
Pressure systems can record force, pressure, contact time, and contact 
area. It is not known whether a high magnitude of pressure or a lower 
pressure acting for long periods of time is more damaging to the foot.23 
Masking software may be used for analysis of regions of interest.
The pedobarograph has been shown to have a lower coefficient of 
variation than the other systems.48 The EMED system was found to be 
highly reliable when at least three recordings were used. Pressure
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measurements have been found to increase linearly with walking speed for 
most sites of the foot.49,51'69 The reliability of the FSCAN measurments 
has not been reported.
A pressure threshold for ulceration was first reported by Boulton et al. 
using pedobarograph measurements in 41 diabetics with neuropathy, 41 
without neuropathy and 41 non-diabetic controls.11 There was a history 
of ulceration in 22 feet, all in the neuropathy group. Pressure was 
significantly higher in the ulcerated group, and all had peak pressures 
greater than 1070 KPa.
Cavanagh and Ulbrecht, using a 1000 element piezoelectric pressure mat, 
collected regional normative peak pressure values on 27 symptom free 
elderly males.24 They determined 750 KPa was a preliminary pressure 
threshold for injury to the foot, based on a 95% confidence limits for 
the regions of highest pressure in the sample population. They noted 
that it is unkown if a single threshold for damage to the foot exists, 
or if regional norms may be necessary. They speculated that pressure 
values dangerous to one area of the foot might be easily tolerated by 
another area.
Veves et al., in a prospective study, found measurements of neuopathic 
deficit and foot pressure were highly predictive of ulceration.'8 They 
followed 86 diabetic patients and 28 non-diabetic controls over a 30 
month period. Initial and follow-up examinations included a neuropathic 
deficit score which was a composite of ratings of reflex responses,
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pain, touch and vibratory sensation, and foot pressure measurements 
using the optical pedobarograph. Neuropathic deficit was found in 58 
patients. Abnormal pressures (greater than 1205 KPa, based on the mean 
peak pressure + 1 SD in normal subjects) were found in 43 patients. 
Fifteen patients developed plantar ulceration. Fourteen of the 15 
patients had neuropathic deficit on initial examination and all 15 had 
abnormal foot pressures. All 15 had neuropathic deficit at follow-up. 
Diabetic patients had a significant increase in pressure, over time, 
compared to non-diabetic controls suggestive of progressive diabetes 
related foot deformity.
Cross-sectional and prospective studies show the relationship of 
pressure and plantar ulceration. Preliminary studies have published 
thresholds for abnormal pressure. These values do not consider 
differences due to foot region, walking speed, and measurement system. 
Pressure measurements are dependent on which measurement system is used, 
the speed at which subjects walk, and the region of the foot measured. 
Studies are needed to establish normal and abnormal thresholds using 
standardized methods for all commercially available pressure systems.
1.4. DEFORMITY AND PLANTAR ULCERATION
Structural deformities may contribute to high pressure in the foot. This 
section defines these deformities and briefly describes the 
pathomechanics related to high pressure and ulceration.
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Several foot deformities have been associated with plantar ulceration in 
diabetes including: claw toes, pes cavus, hallux rigidus (limitus), 
plantar flexed first ray, equinus, rearfoot varus, forefoot varus, 
forefoot valgus, and Charcot deformity.40,70 Claw toes are characterized 
by hyperextension of the metatarsophalangeal, and flexion of the 
proximal and distal interphalangeal joints. These deformities have also 
been associated with a pes cavus (high arch) and callus formation over 
the dorsum of the proximal interphalangeal joint, metatarsal heads 
(MTH), and tips of the toes. Hallux rigidus involves loss of 
metatarsophalangeal joint extension. Inadequate extension during gait 
results in stresses on the plantar surface of the great toe.
Biomechanical deformities (Figure 1.2) are associated with specific 
patterns of abnormal weight-bearing stresses on the plantar surface of 
the foot. 41,46,50,66,76 Rearfoot varus is considered the most common 
biomechanical deformity in the foot. It is a combination of calcaneal 
varus and tibial varus. Calcaneal varus is present when the bisection of 
the calcaneus is inverted relative to the lower one-third of the lower 
leg with the subtalar joint in the neutral position. Tibial varus is the 
degree of inversion of the lower one-third of the lower leg relative to 
the perpendicular weight-bearing line of the limb. Forefoot varus is 
present when the forefoot is inverted relative to the bisect of the 
calcaneus with the midtarsal joint fully pronated. Forefoot valgus is 
present when the forefoot is everted relative to the bisect of the 
calcaneus with the midtarsal joint fully pronated. There are two types 
of forefoot valgus: 1) all the metatarsal heads are everted. 2) the
A DB C
Figure 1.2. Biomechanical deformities in the foot. A, Rearfoot varus. 
B, Forefoot varus. C, Forefoot valgus. D, Plantarflexed first ray.
first MTH is plantar flexed while the second to fifth MTH's lie in the 
same plane. Equinus is a deformity resulting from limitation of ankle 
dorsiflexion. These deformities limit the ability of the foot to rest 
evenly on the ground. The foot may compensate for structural deformities 
by abnormal motion at the subtalar and midtarsal joints. If motion is 
not available the deformities are uncompensated.
Gibbs and Boxer described the relationship of biomechanical deformities 
of the feet and hyperkeratosis.41 They observed that rearfoot and 
forefoot varus were causes of hyperkeratosis along the lateral and 
plantar aspects of the forefoot in the foot lacking compensatory 
pronation. In the varus foot with compensatory pronation and normal 
mobility of the first ray, hyperkeratosis forms on the middle three 
MTH's. In the varus foot with compensatory pronation and a rigid first 
ray, keratosis forms over the first and fifth MTH's. Hypermobility of 
the first ray (excessive dorsiflexion of the first ray during propulsion 
in gait) may also result in abnormal pressure on the medial aspect of 
the great toe called a "pinch callus". Equinus results in increased 
pressure on the first through fourth MTH's because tightness of the 
achilles tendon forces patients to walk on the balls of their feet. They 
noted that in patients with diabetes mellitus and loss of protective 
sensation these deformities may result in ulcer formation and eventually 
deep sinus tracts. Foot orthotics designed to balance the foot with 
structural deformities may reduce mechanical stresses and prevent 
ulceration. 7,45
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Mueller et al. in a retrospective analysis of 40 diabetic patients with 
forefoot and midfoot ulcerations showed a significant relationship 
between deformity and ulcer location.61 Charcot deformity was found in 6 
of 7 midfoot ulcers. Compensated forefoot varus was present in 9 of 11, 
second, third, and fourth MTH ulcers. Ulcers at the first and fifth 
MTH's, however, were found to have either compensated forefoot varus, 
uncompensated forefoot varus, or forefoot valgus. The authors recognized 
that other factors such as limited joint mobility, claw toes, prominent 
MTH's, or plantar flexed first ray deformities may also contribute to 
the localization of foot lesions.
The most severe deformities in diabetic patients are associated with 
Charcot deformities (osteoarthropathies).19 Minor trauma may cause a 
Charcot foot in a diabetic with sensory neuropathy, demineralized bone 
secondary to increased blood flow, or osteoporosis resulting from 
disuse. Initally, Charcot feet present as swollen, warm and red, and are 
easily misdiagnosed as infection. Radiological changes soon occur with 
bone destruction and disruption of articular surfaces. Two well 
recognized deformities develop: a "rocker bottom", associated with 
midtarsal bone destruction and subluxation, and a marked pronated foot, 
resulting from medial dispacement of the talonavicular joint or 
lateroplantar calcaneocuboid dislocation. Both deformities predipose 
ulcer formation in the midfoot.
Cavanagh studied structural changes in the foot using radiography in 
diabetic patients with significant neuropathy and found measurements of
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sesamoid height, first and fifth metatarsal angle, and first metatarsal 
declination angle were significantly related to peak pressure at the 
first MTH using regression analysis.26
Lang-Stevenson et al. found, using pedobarographic pressure studies of 
non-diabetic neuropathic patients, that high pressure over the area of 
healed ulcerations was reduced by surgical correction of deformities.55 
Control studies are lacking to validate the effectiveness of surgery in 
reducing pressure and preventing ulceration.
There is a strong association between deformity and ulceration. 
Deformities may be pre-existing or directly related to diabetes. They 
may be the cause of abnormal pressure which leads to ulceration in the 
neuropathic foot. The location of high stress and ulceration on the foot 
has been associated with specific deformities. Data to support this 
linkage are limited and more research is needed to comfirm present 
theories.
1.5. LIMITED JOINT MOBILITY AND PLANTAR ULCERATION
The finding of joint limitation in diabetic patients is well documented. 
Grigic et al. found joint stiffness in the hands of 65 of 229 children 
with insulin dependent diabetes.44 They noted that short stature, and 
duration of diabetes were related to joint involvement. They believed 
that loss of connective tissue elasticity resulted from an increased 
cross-linking of collagen associated with diabetic metabolic
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abnormalities. Rosenbloom et al. studied the hands of 204 patients with 
insulin dependent diabetes, 336 of their first-degree relatives, and 90 
controls.67 They found limited joint mobility in 21% of patients 
compared to 3% of the parents, 1% of the siblings, and 1% of the 
controls. They concluded that joint stiffness was caused by metabolic 
abnormalities. Buithieu et al. replicated these results in 211 insulin 
dependent diabetics and 239 controls using quantitative goniometric 
measurements of finger and wrist range of motion.21 Campbell et al. 
found decreased motion in the feet and ankles, as well as, the hands, 
wrists and elbows of 254 young insulin dependent diabetics compared to 
110 controls.22 Starkman et al. found an association of limited joint 
mobility in the hand in both insulin dependent and non-insulin dependent 
diabetes.72 They also showed limited joint mobility was related to 
duration of diabetes but only in the insulin dependent group.
There is evidence that both the function and structure of collagen in 
diabetics are changed as a result of hyperglycemia. Free glucose 
spontaneously attaches to proteins by a process known as non-enzymatic 
glycosylation.18,20 Several investigations have shown that joint 
limitation may result from increased non-enzymatic glycosylation which 
leads to the molecular cross-linking of collagen protein and causes 
thickening and stiffness of periarticular tissues.32,68 Hyperglycemia in 
young diabetics may result in the laying down of large amounts of highly 
glycosylated collagen during the puberty growth spurt.22
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The relationship of joint limitation and plantar ulceration was 
established in a study by Delbridge et al.33 Significant joint 
limitation at the subtalar joint was found in diabetics with a history 
of ulceration compared to diabetics without ulceration, and normal 
controls. There was a significant correlation between joint mobility at 
the subtalar joint and the first metatarsophalangeal joint in the foot, 
and the fifth metacarpophalangeal joint of the hand.
Mueller et al. found significantly reduced sensation, ankle 
dorsiflexion, and subtalar joint motion in diabetic patients with 
ulceration compared to controls.60 They demonstrated the linkage of 
neuropathy and joint limitation with plantar ulceration in patients with 
diabetes.
Birke et al. demonstrated the relationship of hallux limitus with great 
toe ulceration. They found significantly decreased great toe extension, 
using a torque range of motion system, in diabetic patients with a 
history of great toe ulcers compared to diabetic patients with a history 
of ulcers at other sites, and non-diabetic controls.8
Limited joint mobility has also been associated with high foot pressure. 
Fernando et al. found, in a study of 30 subjects, that diabetic patients 
with high foot pressure had significantly decreased joint motion in the 
hand and foot, compared to patients without high pressure, and 
controls.38
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In a later study, Fernando et al. studied the relationship of subtalar 
and first metatarsophanageal joint mobility, and pedobarographic 
measurements of pressure in 64 diabetic patients and 15 non-diabetic 
controls.39 They found significantly higher foot pressures in patients 
with limited joint mobility compared to patients, and controls without 
limited joint mobility. Sixty-five percent of patients with neuropathy 
and limited joint mobility had a history of ulceration. There was a 
strong negative correlation between plantar pressures and joint 
mobility.
Cavanagh et al. measured range of motion in the hand, great toe, and 
subtalar joint, and foot pressure, using the optical Pedobarograph, in 
20 insulin dependent and 30 non-insulin dependent patients.25 Regression 
analysis showed decreased subtalar joint mobility and decreased 
vibratory sensation were related to increased pressure. They believe 
that limited joint mobility predisposes a patient to high foot pressure, 
but normal vibratory sensation is protective in avoiding injury to the 
foot during walking.
These studies demonstrate that joint limitation is an important factor 
in increased pressure and plantar ulceration. It has been shown that 
joint limitation is directly related to diabetes. It is not known if 
joint limitation in the foot is related to hyperglycemia, disuse, motor 
neuropathy, or other factors. Joint limitation may result in increased 
foot pressure due to loss of shock absorption, and may focus pressure 
locally because of motion requirements necessary in gait.
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1.6. OTHER FACTORS AND PLANTAR ULCERATION
While deformity and joint limitation have been strongly associated with 
pressure and ulceration in the diabetic foot, other factors may 
contribute to plantar ulcer formation. These factors include: obesity, 
tissue atrophy, and hyperkeratosis.
1.6.1. Obesity
It is reasonable to suspect that individuals with increased weight would 
have increased pressure on their feet. This is an important issue in 
diabetes because obesity is a complicating feature of the disease. 
Boulton found diabetics who developed ulceration had significantly 
longer duration of neuropathy and were significantly heavier.11 Studies 
have shown an association between weight and loading on the foot.29'65,73 
Several studies have not found a significant relationship between body 
weight and pressure.12'24’65,77 Early studies29,73, using force platforms, 
may have shown a stronger relationship between weight and loading, 
because force was not measured per unit of area. Weight gain may result 
in proportional increases in foot mass and tissue padding resulting in a 
normal pressure distribution. Further study is needed to clarify the 




The thickness of the sole pad may also contribute to ulcer formation in 
diabetic patients. Gooding et al. found, by sonography, that the tissue 
under the heel and MTH's was reduced in diabetics compared to 
controls.42 Thinner tissue padding may be due to atrophy of muscle or 
connective tissue, or anterior migration of the metatarsal head pads 
associated with claw toe deformities. Thinning of the tissue over bony 
areas may result in high pressure which might lead to ulceration.
1.6.3. Hyperkeratosis
Delbridge et al. observed increased non-enzymatic glycosylation of 
keratin protein in the stratum corneum of skin, in 30 diabetic patients, 
and proposed that these abnormalities may contribute to hyperkeratosis 
and plantar ulceration.32 Repetitive stresses associated with ambulation 
are the primary cause of callus. Mechanical injuries may develop from 
neglected, thickened callus which cause local high pressure.15,31’36 Young 
et al. measured foot pressures on callused feet of 17 diabetic patients, 
using the pedobarograph, and found removal of callus from 43 sites 
reduced pressure an average of 26%.81 Callus, therefore, is both a cause 
and effect of mechanical stress.
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1.7. SUMMARY AND CONCLUSIONS
Since the early work of Brand there has been a general consensus that 
sensory neuropathy and pressure are primary causes of plantar ulceration 
diabetes. Autonomic neuropathy may render the tissues more susceptible 
to injury, but data in this area are very limited. Brand's observation 
that repetitive walking stresses are the usual mechanism of injury in 
the neuropathic foot has been refined by technological advances in 
pressure measurement. Recent pressure studies have shown that diabetic 
patients with a history of ulceration have higher pressures, and have a 
shift in pressure from the toes to the metatarsal heads compared to non­
ulcerated diabetic and non-diabetic controls. Plantar ulcers occur at 
the areas of highest pressure.
Foot deformity and limited joint mobility contribute to high pressure in 
the diabetic foot. Both pre-existing deformity and deformity related to 
motor neuropathy have been associated with ulceration. A general 
pattern of limited joint mobility is found in diabetes, particularly in 
young patients with insulin dependent patients. In these cases it is 
likely that joint stiffness is due to the non-enzymatic glycosylation of 
protein. In older diabetics, limited joint mobility may also be due to 
other factors such as disuse or motor neuropathy.
Investigators have shown some associations between deformity and 
location of ulcer. For example, hallux limitus is related to great toe 
ulceration, and Charcot deformity is strongly associated with midfoot
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ulceration. A specific association between deformity, joint limitation, 
and location of MTH ulceration is an important unresolved issue because 
ulceration at these locations are so common. Understanding the 
pathomechanics of specific ulcer locations is central to treatment 
approaches.
Foot ulcerations are an important contributing factor to the high 
morbidity in diabetes mellitus. The economic impact of foot problems is 
substanial. Early identification of the patient at risk of ulceration 
has been shown to be beneficial in reducing severe foot complications. 
Foot programs emphasizing preventative care of the feet have 
significantly reduced the amputation rates at a number of 
institutions.2,5,30 An understanding of the pathomechanics of plantar 
ulceration will assist clinicians and researchers in developing better 
methods of preventing and treating ulceration.
Studies of the pathomechanics of ulceration have produced valuable 
direction for the management of the diabetic foot, but 
a number of issues need further investigation. These issues include:
1. Clarification of the role of autonomic neuropathy in 
ulceration of the diabetic foot.
2. Identification of the role of obesity in ulceration.
3. Identification of the deformities or patterns of joint 
limitation responsible for abnormal pressure and 
ulceration at specific sites on the foot.
4. Determination of the role of biomechanically designed
treatment techniques in reducing foot pressure and 
preventing plantar ulceration.
Establishing instrument and location specific normative 
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CHAPTER 2
FIRST RAY JOINT MOBILITY, PRESSURE, AND ULCERATION 
OF THE FIRST METATARSAL HEAD IN DIABETES MELLITUS
2.1. INTRODUCTION
Ulceration is a major cause of disability in patients with diabetes 
mellitus. It has been estimated that twenty-five percent of the fourteen 
million cases of diabetes mellitus in the United States will develop 
foot problems.23 Two hundred million dollars a year is currently spent 
on hospitalization for diabetic foot ulcerations. Addtionally, 60,000 
cases each year require lower extremity amputations at a cost of an 
additional 50 million dollars.45*53 It has been shown that many diabetic 
foot ulcerations can be prevented with early intervention.1,3
Foot ulcers have been shown to be a multicausal problem.10 The major
factors which have been shown to contribute to ulcer formation include
neuropathy, peripheral vascular disease, and abnormal mechanical stress
(pressure).31 Neuropathy and abnormal stresses are considered the
primary causes of plantar ulceration in the diabetic 
f o o t  6,8,12,13,27,62,66,69
Studies on rats and other observational data have supported the belief 
that repetitive stress is the most common mechanism of injury to the 
neuropathic foot.2*12'13*48’52 Brand theorized that in the neuropathic foot 
repetitive walking stresses cause injury, tissue inflammation, but not 
pain. In the absence of normal sensation patients continue to walk in
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the same manner, allowing ulceration to develop. Individuals with normal 
sensation alter their pattern of gait or rest the foot in response to 
the pain associated with tissue inflammation.
Thompson found that abnormal pressure, which contributes to foot 
ulceration, can be divided into intrinsic and extrinsic stresses.66 
Intrinsic stresses result from deformities in the foot and are 
associated with neuropathic plantar ulceration. Extrinsic stresses 
result from external factors, such as, foreign bodies, poor fitting 
footwear or heat and are commonly associated with non-plantar 
ulcerations of a mixed neuropathic and dysvascular etiology.
Boulton proposed that sensory loss was the permissive cause of plantar 
ulceration, but alone was insufficient for wounds to develop. The 
additional factors needed for sufficient cause include high foot 
pressure, callus formation, limited joint mobility and, motor and 
autonomic neuropathy.11
2.1.1. Pressure and Ulceration
Boulton et al. found diabetic patients with a history of plantar 
ulceration had loss of vibratory sensation in the foot and abnormal 
patterns of weight-bearing stresses.8 Several studies have found 
diabetic patients with a history of ulceration have higher peak 
pressures compared to diabetic patients without a history of ulceration, 
or non-diabetic controls, and the locations of ulceration correspond to
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the areas of highest pressure.18’24,65 These studies also show that 
pressure is lower under the toes and higher under the ball of the feet 
of ulcerated patients.
Boulton in subsequent research found the "toe loading ratio" was lower 
in diabetic patients with early evidence of neuropathy compared to 
controls.9 This finding supports the view that structural changes in the 
foot resulting from disease complications contribute to ulceration.
In a recent prospective study of 86 diabetic patients, over a 30 month 
period, 14 of the 15 individuals who developed plantar ulceration had 
sensory neuropathy, and all 15 had abnormally high foot pressures on 
initial examination.69 These data support the casual relationship of 
loss of sensation and high pressure in plantar ulceration.
2.1.2. Deformity and Limited Joint Mobility
Structural deformities, including claw toes, pes cavus, equinus, hallux 
rigidus, rearfoot varus, forefoot varus, forefoot valgus, plantar flexed 
first ray, have been accociated with plantar ulceration. 34,37,51,62 Claw 
toes and pes cavus are believe to result in prominence of the metatarsal 
heads and distal migration of the fat pad, predisposing the metatarsal 
heads to increased pressure and ulceration. Equinus may also contribute 
to ulceration on the metatarsal heads by resulting in a prolonged 
weight-bearing pattern on the forefoot, or compensatory pronation. A 
hallux rigidus deformity has been associatied with plantar ulceration of
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the great toe, as a result of an increased weight-bearing load on the 
great toe during gait.
Mueller et al. showed a significant relationship between Charcot midfoot 
deformity, forefoot valgus, compensated forefoot varus, and 
uncompensated forefoot varus, and ulcer location in a retrospective 
analysis of 40 diabetic patients with midfoot and forefoot 
ulcerations.51 Charcot deformity were present in all 6 midfoot 
ulcerations, and 9 of 11, second through fourth metatarsal head (MTH) 
ulcers were associated with a compensated forefoot varus. Ulcers at the 
first and fifth MTH's, however, were found to have either compensated 
forefoot varus, uncompensated forefoot varus or forefoot valgus. A 
specific deformity was not linked to only first or fifth MTH ulceration. 
The authors noted that other factors, such as limited joint mobility, 
claw toes, prominent metatarsal heads, or a plantar flexion deformity of 
the first ray may have contributed to ulcer location.
Structural deformities measured from radiographs have also been 
associated with foot pressure. Cavanagh found a high declination angle 
of the first metatarsal and a high first and fifth primus varus angle 
were related to first MTH pressure.21
Gibbs and Boxer described the independent function of the first ray and 
its influence on the pattern of foot pressure.37 They proposed that the 
association of a rigid first ray with a compensated forefoot varus 
resulted in increased pressure at the first and fifth MTH's whereas,
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hypermobility of the first ray resulted in pressure at the middle MTH's. 
In the neuropathic foot localization of high pressure at these areas 
could result in ulceration.
Limited range of motion in the ankle and subtalar joints has been shown 
to be decreased in diabetic patients with a history of ulceration 
compared to those without a history of ulceration.29,50 Diabetic patients 
have limited joint mobility in the upper and lower 
extremities16,17,38,58,64 which may be the result of non-enzymatic 
glycosylation of protein associated with hyperglycemia.14,15,28,59 It is 
believed that in diabetes there is an increased cross-linkage of 
collagen causing decreased elasticity and toughening of connective 
tissue around the joint similar to that which occurs with age.
It has been shown that joint hypomobility results in high pressure on 
the foot. Cavanagh in a study of 50 diabetic patients showed that 
limited subtalar motion and loss of vibratory sensation were predictive 
for high pressure in the foot.20 Fernando et al. found subtalar and 
metatarsophalangeal joint motion was reduced in diabetic patients with 
high pressure compared to matched diabetic and non-diabetic controls.32 
Joint hypomobility may decrease the shock absorption function of the 
lower extremity and cause high pressure on the foot. Locally, weight­
bearing stresses may be concentrated at the distal segment of a 
hypomobile joint, which sustains greater resistance to the ground 
reaction forces, during the forward progression of the body in gait.
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The relationship between limited joint mobility and pressure appears to 
be independent of any relationship between limited joint mobility and 
neuropathy. In a study by Fernando et al. diabetics with limited joint 
mobility and neuropathy, or limited joint mobility without neuropathy 
had significantly higher pressures compared to patients with neuropathy 
and no limited joint mobility, diabetic controls, and non-diabetic 
controls.33
Limitation of first metatarsophalangeal joint extension has been shown 
to be related to the development of plantar ulceration of the great 
toe.5’25 Birke et al. showed that diabetic patients with a history of 
great toe ulceration had significantly reduced metatarsophalangeal joint 
extention compared to diabetics with ulcerations at other locations, and 
non-diabetic controls. A relationship between limited joint mobility and 
other locations of ulceration has not been demonstrated.
2.1.3. First Metatarsal Head Ulceration
The first metatarsal head is one of the most common sites of ulceration 
in diabetic patients.4,24 The localization of ulcers at the first MTH may 
be associated with a pattern of deformity or limited joint mobility as 
has been shown to be the case with the great toe, second MTH and 
midfoot. A strong case has been made that hypomobility of the first ray 
may be a critical factor in ulceration that occurs at the first MTH,37 
but investigations have not been made to validate this hypothesis. In a 
neuropathic foot with a compensated rear or forefoot varus, resulting in
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abnormal pronation, the presence of a hypomobile first ray may increase 
pressure at the first MTH. It has been shown that the repetitive 
stresses of walking cause ulceration at areas of high pressure.
2.1.4. Purpose
This investigation studied the relationship of first ray joint 
limitation and first MTH pressure on first MTH ulceration in patients 
with diabetes mellitus. The purpose of this study was to determine if 
(1) limited first ray motion, and high first MTH pressure are related to 
first metatarsal head ulceration in diabetic patients, and (2) if 
limited first ray motion is related to high first MTH pressure.
2.2. METHODS
2.2.1. Subjects
Foot examinations were made on 19 diabetic patients with a history of 
ulceration at the first metatarsal head (U1MTH), 20 diabetic patients 
with a history plantar forefoot ulceration not located at the first 
metatarsal head (UOTHER), 19 diabetic patients with no history of foot 
ulceration (DMCONTROL), and 19 subjects with no history of diabetes or 
symptomatic foot pathology (NCONTROL). Patients in the ulcerated groups 
were selected from the active 1992 files of the Gillis W. Long Hansen's 
Disease Center, Carville, LA. A total of 19 patients with a history of 
first MTH ulceration met the study criteria. Twenty subjects were
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consecutively drawn for the UOTHER group. Individuals with a history of 
ulceration on both feet were only considered once for selection.
Subjects in the DMCONTROL group were volunteers referred from the 
diabetic program, Baton Rouge General Medical Center, Baton Rouge, LA, 
and local newspaper advertisement, who were matched with the U1MTH group 
by age and gender (Appendix C). Subjects in the NCONTROL group were 
volunteer staff and visitors of the GWLHDC matched by age and gender 
with the U1MTH group.
The U1MTH group included patients with documented insulin-dependent or 
non-insulin-dependent diabetes mellitus who had been treated over the 
past 2 years for a first MTH ulceration. The U1MTH group included 
subjects who had a history of plantar ulcer at another site of the 
forefoot. The UOTHER group included patients with documented insulin 
dependent or non-insulin depentend diabetes who had been treated over 
the past two years for a plantar forefoot ulceration, but had no history 
of a first metatarsal head ulceration. Subjects were selected for 
participation in the study only after ulcers were completely healed.
Foot surgery other than soft tissue debridement excluded subjects from 
all groups. The DMCONTROL group included patients with documented 
insulin dependent or non-insulin dependent diabetes but no history of 
ulceration on the foot. The NCONTROL group included non-diabetic 
patients with no history of a foot related disorder. Testing of left and 
right feet were randomized in control groups. All subjects signed an 
informed consent prior to participating in the study (Appendix D).
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2.2.2. Materials
Degrees of first ray dorsiflexion (RAYROM) and kg/cm of first ray 
force/displacement slope (RAYSLOPE) were measured using a modification 
of a measuring device described by Rogers and Cavanagh (Figure 2.I).56 
This instrument stabilized the second through the fifth metatarsal heads 
and measured the vertical displacement of the first ray when a 
controlled force was applied to the first metatarsal head. Vertical 
displacement is assumed to a proportional measurement of dorsiflexion or 
the saggital plane motion of the first ray. While the first ray moves 
about all three body planes, vertical displacement is the standard 
2measurement.57 A parallel placed force transducer, and linear variable 
differential transformer provided simultaneous voltage recordings of the 
force applied and the vertical displacement of the first MTH. A 
miniature oscilloscope (SC 501, Oscilloscope, Tectronix, Inc.,
Beaverton, OR) was used by the tester to visually monitor the force 
applied to the foot. The signals were balanced and calibrated through an 
amplifier (Type R/S Dynograph, Beckman Instruments, Inc.). Recordings 
were stored on a microcomputer (Professional 350, Digital Equipment 
Corp., Maynard, MA) after computerized analogue to digital conversion 
(Model ADMPC - A 2 , Digital Equipment Corp., Maynard, MA). Data were 
reduced and converted into units of kg of force and cm displacement 
using custom written software. Good reliability of the instrument has 
been reported.56 The reliability of RAYROM for two trials of three 
repeated measurements on 73 subjects, using an intraclass correlation 
coefficient (3,1), was 0.93 (Appendix E).22
Figure 2.1. First ray mobility device. Modified from M. Rogers and 
P. Cavanagh. A, Clamp. B, Plunger. C, Force transducer. D, Linear 
variable differential transformer.
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An EMED Pressure System (Novel USA, Minneapolis, MN) was used to measure 
N/cm2 of peak pressure (PRESSURE) and Ns/cm2 of pressure-time integral 
(PRESSURE-TIME) at the first MTH. The pressure platform has a sensor 
area of 445 mm X 225 mm containing 2016 capacitive transducers (2 
transducers per cm2) (Figure 2.2). Measurements were made during the 
second step of three barefoot walks. Patients were provided practice 
walks until a consistent walking pattern was obtained. The length of the 
walk was limited to minimize the risk of re-injury in patients with a 
history of ulceration. The speed of walking was controlled by an 
infrared photo-electric trigger (Model 49310, Radio Shack, Fort Worth, 
TX) and electronic counter (DC 503 Univeral Counter, Tectronix, Inc., 
Beaverton, OR). Data were stored on a microcomputer (Model 286-12D,
Data Storage Marketing Inc.), and analysed using commercial software 
(Multimask EMED Software, Novel USA, Minneapolis, MN). The reliability 
of the EMED platform has been reported to be good when at least three 
2walking trials are used for analysis, and speed of walking is 
controlled.42,44’60 The reliability of measurements of peak pressure for 
three walking trials, on 73 subjects, using an intraclass correlation 
(3,1), was 0.73 (Appendix F).
2.2.3. Secondary Variables
Recordings were made of years of age, kg of weight (WT), cm of height 
(HT), gender (GENDER), sensation, ankle ischemic index (INDEX), years of 
duration of diabetes mellitus (DURATION), type of diabetes (TYPE), joint 
range of motion, joint position and foot radiographs of all subjects.
Figure 2.2. EMED system pressure platform.
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Degrees of range of motion were measured for first metatarsophalangeal 
extension (TOEROM), ankle dorsiflexion (ANKLEROM), total subtalar joint 
motion (STROM) and total hip joint motion (HIPROM). Joint position was 
measured in degrees of varus for midtarsal joint neutral (MTNEUTRAL), 
rearfoot neutral (RFNEUTRAL), and subtalar joint neutral (STNEUTRAL). 
Joint position was measured in degrees of rotation for Hip neutral 
(HIPNEUTRAL). Radiographic measurements were made in cm for first ray 
length (RAYLENGTH), and degrees for the first metatarsal declination 
angle (MTANGLE), and the first and second primus varus angle 
(PRIMUSANGLE).
The ischemic index is a common clinical measure of blood flow to the 
foot.54’70 The index is recorded as a ratio of systolic blood pressure 
in the ankle divided by the systolic blood pressure in the arm. 
Measurements were made of touch sensibility (TOUCH) using Semmes 
Weinstein filaments4 (Manual Arts Department, Gillis W. Long Hansen's 
Disease Center, Carville, LA), and vibration sensibility (VIBRATION) 
using a biothesiometer7 (Bio-thesiometer, Bio-Medical Instrument Go., 
Ohio) as previously reported. Both insturments have been used to 
determine loss of protective sensation in the diabetic foot.4’7,41,63 
Sensation was measured on the distal pulp of the great toe as 
recommended by Foster.34 The three filament sizes used were calibrated 
by the manufacturer and assumed to be log linear.5 Recordings were made 
using a 4 level interval scale. Good reliability of sensory testing 
using Semmes Weinstein filaments has been reported.50 Recordings from 
the biothesiometer were in voltage units on a scale of 0-51. Duration
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and type of diabetes were obtained from the medical record and patient 
interview. Type of diabetes mellitus was recorded as either Type I 
(insulin-dependent) or Type II (non-insulin-dependent). Joint ROM and 
position measurements were made using goniometer methods as described by 
Fromherz.35 Good reliability of range of motion and position 
measurements in the foot has been reported.50
Standardized anterior/posterior and lateral radiographs were taken in a 
standing weight-bearing position by the radiology technician, Gillis W. 
Long Hansen's Disease Center, Carville, LA. Measurements of RAYLENGTH, 
MTANGLE and PRIMUSANGLE were made directly on the x-ray film using a 
straight edge and compass as described by Weissman.71
2.2.4. Procedure
All subjects were interviewed and secondary variables measured and 
recorded. Measurements of first ray motion were made with the subject 
sitting at 90 degrees of hip and knee flexion with the foot and leg in 
their normal stance relationship. The foot was clamped in the first ray 
mobility device so that the lesser metatarsals were securely immobilized 
and the first ray was free to move through full range of motion. A 
dorsiflexion force was applied to the first ray by a manually operated 
plunger composed of a force transducer and parallel linear variable 
differential transformer (Figure 2.1). The applied force was displayed 
on an oscilloscope which provided a visual feedback to the tester, so 
that a standard, non-injurious force could be applied to all subjects.
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The tester attempted to apply the force consistently at a moderate rate. 
Two trials of three cyclical loadings and unloadings to a maximal force 
of approximately 10 kg were made on each subject. The mean of six 
measurements of RAYSLOPE and RAYROM at 8 kg of force were used for 
analysis. Group differences in first ray length were determined by 
lateral radiographs. Differences in ray length could result in 
systematic measurement error of first ray mobility.
Pressure was measured on subjects walking across an EMED System pressure 
platform. Each subject was given practice trials to ensure a smooth 
placement of the foot on the pressure platform. A walking rate of .555 
+ .035 m/s was used for all subjects. This rate was determinied during 
pilot testing to be comfortable for all groups. Data were collected from 
three trials. The mean of three measurements of PRESSURE and PRESSURE­
TIME for the first MTH mask region was used for analysis (Appendix G).
2.2.5. Data Analysis
A multivariate analysis of variance (MANOVA) was used to test the 
overall treatment group effect for primary and secondary response 
variables. Analysis of variance (ANOVA) was used to determine which 
varibles had a group effect. An alpha level of 0.0125 (0.05/4), 
determined by a Bonferroni procedure, was used for ANOVA of the four 
primary response variables. This approach controls for Type I 
experimentwis.e error by reducing the alpha level proportional to the 
number of comparisons made. An alpha level of 0.05 was used for
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comparison of secondary variables. A Tukey's studentized range test at 
an alpha level of 0.05 was used for group mean comparisons. The Tukey's 
test controls for Type I error associated with post hoc comparisons. 
Group differences in gender and type of diabetes were analysed using a 
chi-square test which is appropriate for dichotomous scales. A stepwise 
regression analysis was used to determine the relationship of primary 
and secondary response variables on the dependent variables PRESSURE and 
PRESSURE-TIME. The data were further analysed by discriminate analysis 
to identify variables which best characterize the three diabetic groups 
from each other.
2.3. RESULTS
MANOVA showed a significant overall group effect (Wilk's Criterion, p < 
0.0001). ANOVA's (Appendix J) showed a significant group effect for 
response variables: TOUCH (p < 0.0001), VIBRATION (p < 0.0001), RAYROM 
(p < 0.0001), RAYSLOPE (p < 0.0001), PRESSURE (p < 0.0001), PRESSURE­
TIME (p < 0.0001), TOEROM (p < 0.0006), ANKLEROM (p < 0.0084), STROM (p 
< 0.0005), HIPROM (p < 0.0001), DURATION (p < 0.0209). AGE, HT, WT, 
INDEX, RFNEUTRAL, MTNEUTRAL, HIPNEUTRAL, RAYLENGTH, MTANGLE, and 
PRIMUSANGLE were not statistically significant. Chi-square tests showed 
no significant group effect for the categorical variables GENDER and 
TYPE (Appendix K).
RAYROM was significantly lower in U1MTH compared to UOTHER, DMCONTROL an 
and NCONTROL. RAYSLOPE, PRESSURE, and PRESSURE-TIME was significantly 
higher in U1MTH compared to UOTHER, DMCONTROL and NCONTROL (Table 2.1).
TOUCH and VIBRATION, were significantly higher in both ulcerated groups 
compared to controls, and TOUCH was significantly higher in DMCONTROLS 
compared to NCONTROLS (Table 2.3). DURATION was sigificantly higher in 
both ulcerated groups compared to diabetic controls. TOEROM, STROM, and 
HIPROM were significantly reduced in both ulcerated groups compared to 
controls, and ANKLEROM was significantly lower in the U1MTH group 
compared to controls (Table 2.4).
Stepwise linear regression showed RAYROM, PRIMUSANGLE and MTNEUTRAL to 
be the most significant predictors of PRESSURE, and PRESSURE-TIME over 
all subjects (Tables 2.7 and 2.8). The coefficient of determination 
(R2) and F ratio show RAYROM had a significantly stronger relationship 
with PRESSURE (R2 = .45, p < 0.0001) than response variables PRIMUSANGLE 
(R2 = .04, p < 0.0124) or MTNEUTRAL (R2 - .02, p < 0.1044). The 
coefficient of determination (R2) and F ratio show RAYROM had a 
significantly stronger relationship with PRESSURE-TIME (R2 = .40, p < 
0.0001) than response variables PRIMUSANGLE (R2 = .02, p < 0.0966) or 
MTNEUTRAL (.03, p < 0.0723). Plots of residuals showed regressors 
RAYROM, PRIMUSANGLE and MTNEUTRAL fit a linear model.
A discriminate analysis (Candisc procedure, SAS) showed a pronounced 
separation between the three diabetic groups relative to the primary
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canonical structure (Figure 2.3). The variables which best 
discriminated the three diabetic groups based on discriminate 
coefficients were TOUCH (0.8646), RAYROM (- 0.7542) and PRESSURE-TIME 
(0.6715).
A stepwise discriminate analysis (Table 2.9 and 2.10) (Stepdisc 
procedure, SAS) showed variables RAYROM, PRESSURE-TIME, and HT were 
significant discriminators between UIMTH and UOTHER, and response 
variables TOUCH, RAYROM, TOEROM, DURATION, and RFNEUTRAL were 
significant discriminators between UIMTH + UOTHER (all ulcerated 
patients) and DMCONTROL.
Discriminate analysis between ulcer groups showed RAYROM was a 
significantly stronger discriminator (R2 = .40, p < 0.0001) between 
ulcer groups than PRESSURE-TIME (R2 - .17, p < 0.0085) or HT (R2 = .10, 
p < 0.0594).
The discrimation model for UIMTH versus UOTHER resulted in two cases of 
misclassification into UIMTH and two cases of misclassification into 
group UOTHER. The discrimination model for group UIMTH + UOTHER versus 
DMCONTROL resulted in no misclassifications into UIMTH + UOTHER and two 
misclassifications for entry into DMCONTROL.
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Table 2.1










UIMTH .09 ± .26a 12.1 ± 2.4a 87.1 ± 25.8a 38.1 ± 15.la
UOTHER .52 ± . 27b 10.3 ± 1.9b 49.5 ± 29.8b 17.8 ± 11.9b
DMCONTROL .69 ± . 18b 8.9 ± 1. 6b 39.2 ± 20.9b 13.3 ± 6.3b
NCONTROL .64 ± . 26b 9.7 ± 2 . lb 40.7 ± 21.3b Ul 1+ 00 00 cr
a’b p < 0.05
Table 2.2
Group Means and Standard Deviations or Ratios for 
Physical Characteristics
Groups Age Gender Weight Height
years male/female kg cm
UIMTH 56.3 ± 13.4 7/12 88.1 ±17.6 26.8 ±1.7
UOTHER 54.5 ±11.4 11/9 85.3 ±17.2 26.9 ± 1.6
DMCONTROL 56.4 ±13.2 7/12 92.6 ±26.7 25.9 ±1.1
NCONTROL 57.1 ±12.3 7/12 89.0 ± 11.2 26.1 ±1.2
Table 2.3












UIMTH 4/15 20.7 ± 11.9a 3.8 ± 0.4a 42.3 ± 10. 3a 0.97 ± .2
UOTHER 5/15 20. 3 ± 10. 4a 3.7 ± 0.5a 42.0 ± 9.9a 1.03 ± .2
DMCONTROL 9/10 10.9 ± 13.lb 1.7 ± 1.0b 21.3 ± 13.7b 0.94 ± .1
NCONTROL -- 1.1 ± 0.3C 12.5 ±7.8b 1.03 ± .1
Note. TYPE = type of diabetes, TOUCH = Semmes Weinstein 
filaments, VIBRATION = bio-thesiometer, INDEX = ischemic index 
a’b'c p < 0.05
Table 2.4
Group Means and Standard Deviations for Degrees 
of Joint Range of Motion
Groups TOEROM ANKLEROM STROM HIPROM
UIMTH 34.7 ± 14.2a 2.2 ± 4.2a 24.7 ± 7.4a 76.0 ± 13.9a
UOTHER 31.6 ± 13.0a 3.6 ± 3. 3ab 25.7 ± 5.9a 77.0 ± 16. 2)a
DMCONTROL 46.8 ± 10.0b 5.9 ± 3.8b 32.3 ± 6.8b 89.9 ± 15.6)b
NCONTROL 47.2 ± ll.lb 5.9 ± 4.3b 31.7 ± 6.5b 94.2 ± 10.9b
Note. TOEROM = first metatarsophalangeal extension,
ANKLEROM = ankle dorsiflexion, STROM = total subtalar motion, 
HIPROM = hip motion 
a’b p < 0.05
Table 2.5
Group Means and Standard Deviations for Degrees 
of Neutral Joint Position
Groups MTNEUTRAL RFNEUTRAL HIPNEUTRAL


















Group Means and Standard Deviations 
for Radiographic Measurements
Groups RAYLENGTH MTANGLE PRIMUSANGLE
cm degrees degrees
UIMTH 9.0 ± 0.5 20.1 - 2.7 9.7 ±3.2
UOTHER 8.9 ± 0.4 20.0±3.8 8.6±3.3
DMCONTROL 8.8 ±0.4 21.0 ±3.1 10.3 ±3.0
NCONTROL 8.9 ±0.4 21.4 ±3.3 10.3 ±2.8
Table 2.7
Summary of Stepwise Regression Analysis for 
the Dependent Variable Peak Pressure
Step Entered Partial R2 F ratio Probability
1 RAYROM 0.4558 62.8079 0.0001
2 PRIMUSANGLE 0.0444 6.5731 0.0124
3a MTNEUTRAL 0.0179 2.7047 0.1044
Note. RAYROM = first ray dorsiflexion,
- PRIMUSANGLE = primus varus angle,
MTNEUTRAL = midtarsal neutral position 
Note. Significance level to enter and stay was 0.15 
aStep 3 model, PRESSURE = 66.128179 +
RAYROM (-64.142351) + MTNEUTRAL (-0.86027) + 
PRIMUSANGLE (2.260636)
Table 2.8
Summary of Stepwise Regression Analysis for 
the Dependent Variable Pressure-time Integral
Step Entered Partial R2 F ratio Probability
1 RAYROM 0.3969 49.3602 0.0001
2 PRIMUSANGLE 0.0222 2.8328 0.0966
3a MTNEUTRAL 0.0253 3.3256 0.0723
Note. RAYROM = first ray dorsiflexion, 
PRIMUSANGLE = primus varus angle,
MTNEUTRAL = midtarsal neutral position 
Note. Significance level to enter and stay 0.15 
aStep 3 model, PRESSURE-TIME = 28.655563 +
RAYROM (-28.021392) + MTNEUTRAL (-0.484311) + 
PRIMUSANGLE (0.787932)
Table 2.9
Stepwise Discriminate Analysis between Diabetic 
Patients with a History of First Metatarsal Head 
Ulceration and Diabetic Patients with a History 
of Other Forefoot Ulceration
Step Entered Partial R2 F - Ratio Probability
1 RAYROM 0.4042 25.099 0.0001
2 PRESSURE-TIME 0.1773 7.758 0.0085
3 HT 0.0979 3.798 0.0594
Note. RAYROM = first ray dorsiflexion,
PRESSURE-TIME = pressure-time integral, HT = height 
Note. Significance level to enter ana stay 0.15
Table 2.10
Stepwise Discriminate Analysis between Diabetic 
Patients with a History of Ulceration and 
Diabetic Patients with no History of Ulceration
Step Entered Partial R2 F - Ratio Probability
1 TOUCH 0.6796 118.798 0.0001
2 RAYROM 0.0674 3.974 0.0512
3 TOEROM 0.0459 2.600 0.1127
4 DURATION 0.0483 2.687 0.1071
5 RFNEUTRAL 0.0479 2.616 0.1118
Note. TOUGH = Semmes Weinstein filaments,
RAYROM = first ray dorsiflexion,
TOEROM = first metatarsophalangeal extension, 
DURATION = duration of diabetes,
RFNEUTRAL = rearfoot neutral 
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Figure 2.3. Discriminate analysis. Plot of canonical structures for diabetic 
groups. X, No history of ulceration. Y, Ulceration not at the first metatarsal 
head. Z, Ulceration at the first metatarsal head.
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2.4. DISCUSSION
Mean dorsiflexion was only 0.09 cm for U1MTH compared to 0.52, 0.69 and 
0.64 cm for UOTHER, DMCONTROL and NCONTROL respectively which shows the 
UlMTH group functions in relative plantar flexion (Figure 2.4) compared 
to the other groups. The first metatarsal is considered plantarflexed 
when the major portion of total dorsiflexion to plantarflexion is 
plantar to the relative plane of the lesser metatarsal heads.57
Abnormal pressure and ulceration at the first MTH has been associated 
with plantar flexion deformity in the foot.37 Slope of the force/motion 
curve has been shown to be a good indicator of joint stiffness where 
joint stiffness is defined as the change in motion/change in force.5 In 
this study the slope of the force displacement curve was significantly 
higher in the UlMTH group showing the first ray was stiffer in these 
patients.
PRESSURE in the UlMTH patients was more than twice that of controls and 
almost twice that of UOTHER (Figure 2.5). PRESSURE-TIME was two and a 
half times that of controls and more than twice that of UOTHER. These 
data support previous studies which have found patients with a history 
of plantar ulcerations have significantly higher foot pressure, 
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Figure 2.4 First ray motion for groups.






















Figure 2.5. Peak pressure first metatarsal head for groups.
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Normal and abnormal pressure thresholds have not been determined for the 
EMED system. The mean + 1 SD in normal subjects has been recommended for 
abnormal pressure thresholds.68 In this study using NCONTROL group data 
the abnormal pressure threshold was determined to be 62.0 N/cm2 (620 
KPa). This value is lower than abnormal thresholds previously reported 
using the Pedobarograph68 and Penn State University piezoelectic mat.19 A 
lower pressure value using the EMED System may be due to the instruments 
poorer resolution.19 Normal and abnormal data for PRESSURE-TIME is not 
available. In this study, using the mean + 1 SD in normal subjects, the 
abnormal PRESSURE-TIME threshold was determined to be 23.9 Ns/cm2 (239 
KPa-s). It is not known whether PRESSURE which measures the magnitude of 
pressure, or PRESSURE-TIME which measures the total pressure acting over 
a period of time is more damaging to the foot.18
These results support the study hypotheses that the first ray is stiffer 
and limited in dorsiflexion, and the first MTH has higher pressures 
during walking in diabetic patients with a history of first MTH 
ulceration. During walking, stiffness in the first ray, may contribute 
to high pressure and ulceration at the first MTH. The issue of whether 
limited first ray mobility is a cause or an effect of ulceration must be 
considered. The retrospective research design used in this study 
restricts conclusions that a causal link exists. Alternatively, 
limitation of first ray motion may have resulted from such factors as 
post-healing scar, treatment immobilization, or disuse. The literature, 
however, presents strong theory and supportive data that limited joint 
mobility from a pre-existing condition or secondary disease complication
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results in high foot pressures. Limited first ray mobility may result in 
high stresses on the first MTH which in the neuropathic foot may lead to 
tissue injury and ulceration.
2.4.1. Discussion of physical characteristics
Age, gender, and obesity are related to diabetes and diabetes 
complications.26’47,68 Obesity has been shown to be a risk factor for Type 
II diabetes and may be a factor in ulceration.26,36 In this study, age 
and gender were controlled variables between the UlMTH, DMCONTROL and 
NCONTROL groups, to eliminate their possible effect on joint mobility or 
pressure. Weight and height were not significantly different between 
groups. Weight differences between groups were expected. Veves found 
diabetic patients were significantly heavier than non-diabetic controls, 
but no difference was found between those with and without neuropathy.
These findings suggest that weight is not a specific risk factor in 
plantar ulceration.68 There is a question as to whether body weight is 
related to foot pressure. Recent studies have contradicted early reports 
that weight is a predictor of foot pressure.22,24'65
2.4.2. Discussion of disease indicies
There were 3 times more Type II diabetes within the ulcerated groups. 
(Table 2.3). Foot ulcerations occur in both Type I and II diabetes. Type 
II diabetes is more common than Type I26 which explains the distribution
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found in this study. The finding of no difference between groups for 
INDEX supports the belief that poor circulation is not a cause of 
plantar ulceration. Sensory measurements TOUCH and VIBRATION were 
significantly higher in both ulcer groups (UlMTH and UOTHER) compared to 
controls groups. This finding is consistent with numerous studies that 
have shown sensory loss is strongly associated with ulceration and may 
be the primary cause of plantar ulceration.
The lowest TOUCH threshold for the ulcerated patients in this study was 
the #3 filament (75 gram). Several studies have recommended the use of 
the #2 filament (10 gram) as the threshold level for protective 
sensation,4’41,50 while others have recommended a lower threshold 
level.46'63 In this study no patient in the ulcerated groups could feel 
the #2 filament at the great toe. The lowest threshold for 
biothesiometer testing of the great toe in ulcerated patients was 21 
volts. Bloom et al. recommended age adjusted Centile Charts for use in 
assessing diabetic peripheral neuropathy.7 They found for biothesiometer 
testing the mean and standard deviation for the age 50 was 12.1 + 7.9 
volts. Their values are extremely close to the vibratory thresholds 
obtained on the NCONTROL group (12.5 + 7.8 volts). The upper threshold 
of normal (mean + 2 SD) using NCONTROL values or Bloom's data is 28 
volts. A protective threshold level for the diabetic foot, based on the 
normal mean + 2 SD, would result in several false negatives in this 
study. Early detection of loss of protective sensation may identify 
diabetic patients most at risk of ulceration and in need of preventative 
care.
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TOUCH threshold was significantly increased in DMCONTROL versus 
NCONTROL. Biothesiometer testing did not show a significant difference 
between control groups. This finding supports previous studies that 
found the Semmes Weinstein filaments were more sensitive than the 
biothesiometer in detecting sensory neuropathy.46,63
Duration of diabetes was significantly increased in ulcerated groups 
compared to DMCONTROL. This finding is consistent with 
previous data that duration of diabetes is a stong risk factor in 
diabetic complications.47
2.4.3. Discussion of range of motion
Mueller found mean degrees STROM was 25.5 + 8 in diabetics with 
ulceration, compared to 30.5 + 10 in diabetic controls, and 34.5 + 7 in 
non-diabetic controls.50 Mueller found mean degrees ANKLEROM was 2.0 +
8 in diabetics with ulceration, compared to 5.0 + 3 in diabetic 
controls, and 6.5 + 4  in non-diabetic controls. There is strong 
agreement between the findings of Mueller and this study (Table 2.4) 
that diabetic patients with a history of ulcertion have significantly 
smaller motion compared to their diabetic and non-diabetic controls.
Both studies used standard goniometric techniques, and the similarity in 
data between both studies supports the validity of the methods used.
TOEROM, STROM, ANKLEROM, and HIPROM do not appear specifically related 
to first MTH ulceration since joint range of motion was not
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significantly different between ulcer groups. These data support 
previous reports which show the association of limited joint mobility 
and ulceration in diabetics. Hyperglycemia is believed to result in a 
generalized pattern of joint limitation in the upper and lower 
extremity. It has been proposed that joint limitation in the foot 
reduces the shock absorption during walking and increases tissue 
stresses. Shock absorption is a function of the subtalar joint at the 
heal strike phase of gait.30 Limited ankle dorsiflexion more likely 
contributes to ulceration by high forefoot pressure resulting from an 
early heel rise or compensatory pronation during the stance phase of 
gait.37’40’*3,57’67
This study is the first to show the relationship between limitation of 
hip motion and diabetic ulceration. Limited hip motion may increase 
stresses in the foot by abnormal pronatory or supinatory forces on the 
foot due to a reaction through the closed kenetic chain.43
2.4.4. Discussion of neutral position
Differences in MTNEUTRAL and RFNEUTRAL were expected. The literature 
suggests that rearfoot varus, forefoot varus and forefoot valgus 
contribute to abnormal patterns of pressure in the forefoot. The UlMTH 
group had a mean MTNEUTRAL position of 2.4 degrees valgus (indicated by 
the negative sign) compared to a varus position for the other groups 
(Table 2.5). A MTNEUTRAL valgus includes subjects with a first through 
fifth eversion and those with a plantar flexed first ray. The latter may
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be the more common in the UlMTH group. The lack of significance of this 
finding is due to a large variation in the data as noted by the SD 
valtaes. One source of variation may be measurement error. Fromherz 
reported that quantifiable forefoot neutral position measurements are 
difficult to obtain.35 There may also be true variation in the data. 
Mueller found both varus and valgus were related to ulceration at the 
first MTH.26
2.4.5. Discussion of radiographic measurements
There was no difference in first ray length among groups (Table 2.6). It 
is, therefore, assumed that the torque applied to the first ray during 
mobility measurements was the same among groups.
A larger MTDA was expected in the UlMTH group. MTDA is associated with a 
cavus or supinated foot, a rigid plantar flexed first ray, and 
uncompensated rearfoot varus which may contribute first MTH pressure. In 
contrast, a smaller MTDA and larger primus varus angle is associated 
with a pes planus or pronated foot, a hypermobile first ray which may 
contribute to central MTH pressure.57’67’71 The group mean data do not 
support these effects.
2.4.6. Discussion of regression analysis
The finding on regression analysis, that reduced RAYROM is a strong, 
negative predictor of PRESSURE and PRESSURE-TIME across all treatment
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groups, supports the theory that limited motion of the first ray is a 
cause of pressure at the first MTH. These results disagree with the 
findings of Rogers who in a study of normal male subjects showed weight, 
the arch index (a measure of arch height) and height were related to 
regional pressure, but not first ray mobility.55 There are several 
possible reasons Rogers failed to show a relationship between first ray 
mobility and pressure. First, for the purpose of simplifying the 
analysis, pressures were averaged over general areas of the foot (toes, 
ball, arch) and first ray mobility was never analyzed with first 
metatarsal head pressure. Second, her sample included a narrow 
population (normal males) which provided a limited range of data for 
regression analysis. Lastly, she analyzed only force discplacement data 
and did not measure first ray dorsiflexion.
2.4.7. Discussion of discriminate analysis
Discriminate analysis showed: 1) of the two sensory measures TOUCH was a 
stronger discriminator than VIBRATION, 2) of the two first ray mobility 
measures RAYROM was a stronger discriminator than RAYSLOPE, and 3) of 
the two pressure measures PRESSURE-TIME was a stronger discriminator 
than PRESSURE. Limited dorsiflexion may contribute more to plantar 
ulceration than stiffness, and pressure over a longer period of time may 
be more critical in tissue injury that magnitude of pressure.
Discriminate analysis supported the relationship between RAYROM and 
PRESSURE-TIME to first MTH ulceration which was found in ANOVA and
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regression analysis. Ht was also shown to be a discriminator between 
ulcer groups. Rogers showed a relationship between height and pressure 
in normal subjects.55 It may be that tall individuals with large feet 
have higher plantar stresses, and are more susceptible to first MTH 
ulceration than shorter individuals. This finding deserves further 
study.
Both the cases of misclassification in the discrimination model for 
UlMTH versus UOTHER had a history of fifth MTH ulceration and associated 
plantar flexion of the first ray deformity. These individuals would be 
expected to have a high pressure over both the first and fifth MTH's and 
therefore at risk of first or fifth MTH ulceration.37 The two 
misclassifications in the discrimination model for group UlMTH + UOTHER 
versus DMCONTROL may be cases with a very high risk of ulceration.
2.4.8. General discussion
In this study several methods of data analysis show a strong association 
between sensory loss, limited range of motion, high pressure and 
ulceration. Boulton reported that several component causes, including 
sensory loss, abnormal pressure, and limited joint mobility, were 
necessary for plantar ulceration to develop. Sensory loss permits injury 
to the tissues of the foot. Injuries result from high pressures due to 
such factors as limited joint mobility. These findings suggest that 
limited first ray mobility may specifically contribute to ulceration at
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the first MTH. Prospective studies are needed to validate the causal 
relationship of limited first ray mobility in first MTH ulceration.
Previous studies have shown that there is a generalized pattern of 
limited joint mobility associated with the complications of diabetes. In 
this study range of motion at the great toe, subtalar joint, ankle, and 
hip was smaller in both ulcerated groups compared to controls. Ulcerated 
patients were found to have advanced disease based on a longer duration 
of diabetes and a lower sensory level compared to DMCONTROLS. In 
contrast, limitation of motion at the first ray and high pressure were 
found only in the UlMTH group. Limited first ray motion may result from 
other causes such as a pre-existing biomechanical deformity. Further 
study is needed to determine the cause of deformity and limited joint 
mobility in diabetes.
The research design used in this study compared the feet of different 
individuals. In an alternative design, where both feet of each subject 
would be measured, comparisons of joint mobility could be made with the 
uninvolved leg. A finding of lower first ray mobility in the ulcerated 
limb compared to the non-ulcerated limb would have provided additional 
support that a relationship between hypomobility and ulceration exists.
A study comparing the contralateral limb would have provided control for 
subject differences due to disease, age and gender. While contrasts 
with the contralateral limb would have been of interest, the additional 
time of testing would have limited the availability of volunteer 
subjects and increased the risk of patients injurying their feet during
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barefoot walking. Future studies should focus on the joint mobility of 
the contralateral limb in ulcerated patients.
Currently, diabetic foot ulcerations are treated with limited success. 
While the mechanical factors in plantar ulceration are well documented, 
there remains a strong emphasis on the use of topical agents to promote 
wound healing. Expensive methods, such as growth factors and hyperbaric 
oxygen, are promoted by wound care centers while simple, less expensive 
orthotic devices are under-utilized. Medicare and private insurance 
often reimburse diabetic patients for topical, wound care agents, 
hyperbaric treatments and surgery, but not for healing devices and 
footwear. This study provides data which support the view that limited 
joint mobility and an associated plantar flexion deformity of the first 
ray are primary causes of mechanical stresses leading to first 
metatarsal head ulceration in diabetic patients. Efforts should be made 
to identify this deformity in early diabetic cases and to develop 
treatment methods to reduce the deformity or reduce the associated 
stresses on the first metatarsal head.
Measurement of first ray motion, sensation and pressure may be valuable 
in identifying early cases who are at risk of first MTH ulceration. 
Patients with neuropathy, limited first ray mobility and high pressure 
may benefit from orthotics and footwear which reduce the impact of 
plantar flexion of the first ray during walking. Orthotics designed with 
lateral forefoot posts have been recommended to balance a plantar flexed 
first ray deformity.40 Footwear with soft, elastic insoles and
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outersoles may increase shock absorption resulting from limited first 
ray mobility. Prospective studies are needed to determine if balanced 
orthotics and cushioned footwear reduce the risk for first MTH 
ulceration. Additionally, exercises may be useful in increasing first 
ray motion. Mobilization of the first ray and passive exercises may 
increase joint range of motion particularly if the glycosylation of 
collagen protein is a contributing factor. Exercises may not improve 
range of first ray motion if limitation is the result of a pre-existing 
biomechanical deformity. Studies are needed to determine if exercise 
improves the range of joint motion in the feet of diabetic patients.
2.5. SUMMARY AND CONCLUSIONS
This study showed that diabetic patients with a history of first MTH 
ulceration had significantly limited first ray mobility, and high 
pressure at the first MTH compared to diabetics who ulcerated at other 
locations, and matched diabetic and non-diabetic controls. Limited first 
ray mobility was shown by regression analysis to be a strong predictor 
of pressure at the first MTH across all subjects in the study. In 
combination, these findings support the view that limited first 
ray mobility is a cause of high stress and a component factor in 
ulceration at the first MTH in diabetic patients.
Analysis of secondary variables showed duration of diabetes was higher 
in diabetic patients with a history of ulceration compared to controls, 
whereas sensation, range of motion at the great toe, subtalar joint,
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ankle and hip were significantly lower. Additionally, Semmes Weinstein 
sensory measurements showed that diabetic patients with no history of 
ulceration had reduced foot sensation compared to non-diabetic controls. 
Discriminate analysis showed RAYROM was the strongest discriminator 
between the ulcer groups. PRESSURE-TIME also provided meaningful 
discrimination. Sensory loss measured by Semmes Weinstein filaments 
provided very strong discrimination between ulcerated diabetics and non­
ulcerated diabetic controls.
These results demonstrate that the pathomechanical factors, limited 
joint mobility and high pressure, are significantly related to plantar 
ulceration and ulcer location in diabetes. Management of joint 
limitation may be a valuable approach in the prevention and treatment of 
plantar ulceration in diabetes.
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APPENDIX A
ABBREVIATIONS USED IN TEXT
ANKLEROM ankle dorsiflexion
DMCONTROL diabetes mellitus control group
DURATION duration of diabetes
GENDER gender
HIPNEUTRAL hip neutral
HIPROM hip range of motion
HT height
INDEX ischemic index




NCONTROL normal control group
PRESSURE-TIME pressure-time integral
PRESSURE peak pressure
PRIMUSANGLE primus varus angle
UlMTH ulcer first metatarsal group
UOTHER ulcer other group
RAYROM first ray dorsiflexion
RFNEUTRAL rearfoot neutral
RAYLENGTH first ray length
ROM range of motion
RAYSLOPE first ray slope
STNEUTRAL subtalar neutral
STROM subtalar range of motion
TOUCH Semmes Weinstein filament sensation
TYPE type of diabetes




BIOMECHANICAL CONVERSIONS FOR STRESS (PRESSURE)
1 kg/cm2 — 14.22 lb/in2 = 9.807 N/cm2 — 98.07 KPa = 735.174 mm Hg 
1 lb/in2 - 0.6897 N/cm2 - O' . 07032 kg/cm2 - 6.897 KPa — 51.7 mm Hg 
1 N/cm2 — 1.45 lb/in2 = 0.102 kg/cm2 — 10 KPa = 74.965 mm Hg 
1 KPa = 0.145 lb/in2 = 0.0102 kg/cm2 = 0.1 N/cm2 = 7.4965 mm Hg 
1 mm Hg = 0.01934 lb/in2 = 0.00136 kg/cm2 = 0.01334 N/cm2 = 0.13339 KPa
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APPENDIX C
MATCHING BETWEEN THE UlMTH AND CONTROL GROUPS FOR 



























Abstract For Informed Consent 
Gillis W. Long Hansen's Disease Center
Title of Study: Limited First Ray Dorsiflexion, Increased Pressure and 
Ulceration at the First Metatarsal Head in Diabetic Patients
Investigator: James A. Birke
Purpose of Investigation: determine if joint stiffness is a cause of 
high pressure and ulceration at the first metatarsal head (area behind 
the big toe) in the feet in patients with diabetes mellitus. High 
pressure is believed to be an important cause of ulceration (open sores) 
in the feet of diabetic patients.
Procedures:
1. All diabetic patients will first be examined by a physician of the 
GWLHDC for medical clearance to participate in the study.
2. Two X-rays will be made of the sample foot to measure the length and 
inclination angle of the bones behind the big toe.
3. Measurements of the motion of the feet and ankles will be made using 
a goniometer (angle measuring device) while standing, and lying on a 
table.
4. While seated in a chair the foot will be secured firmly into a device 
which will measure motion of the bones behind the big toe. A plunger 
will push the bones upward and motion will be recorded electronically. 
The force will be moderate to minimize the risk of pain or injury to the 
foot during testing.
5. Subjects will walk barefoot on a platform which measures pressure on 
the foot. This instrument determines if areas of the foot are getting 
high pressure during walking. The platform is padded with a material 
used to make shoe insoles to minimize the risk of injury to the feet 
during walking barefoot.
There are no direct benefits or compensation to you for participating in 
this study. The data obtained from your participation will be kept 




* To Be Retained By The Investigator
EXPERIMENT SIGN-UP FORM
My signature, on this sheet, by which I volunteer to participate in 
the experiment on Limited first rav dorsifexion. increased pressure and 
ulceration at the first metatarsal head in diabetic patients___________
conducted by James A. Birke____________________________________________
Experimenter
indicates that I understand that all subjects in the project are 
volunteers, that I can withdraw at any time from the experiment, that I 
have been or will be informed as to the nature of the experiment, that 
the data I provide will be anonymous and my identity will not be 
revealed without my permission, and that my performance in this 
experiment may be used for additional approved projects. Finally, I 
shall be given an opportunity to ask questions prior to the start of the 
experiment and after my participation is complete.
Subject's signature
APPENDIX E
RELIABILITY OF THE FIRST RAY MOBILITY DEVICE
Reliability measurements of first ray dorsiflexion (cm) for the mean of 
three oscillations in two trials of testing on the first ray mobility 
device in 73 subjects. Four subjects were not included because of 
missing data.





















































































































































Mean and standard deviation 
for first ray mobility trials
Trial 1 
Trial 2
.52 ± 0.36 cm 
.47 ± 0.33 cm
ANOVA summary table for two trials of testing
on the first ray mobility device
Source df MS F
Subjects 72 .2293 27.6842
Trials 1 .1063 12.8313
Residual 72 .0082
Intraclass correlation coefficient (3,1) = .9302
APPENDIX F
RELIABILITY OF THE EMED SYSTEM
Reliability of pressure measurements (N/cm2) for three trials of walking 
on the EMED System platform on 73 subjects. Four subjects were not 
included because of missing data.












































































Mean and standard deviation
for EMED trials
Trial 1 51.67 ± 34.03 N/cm2
Trial 2 50.01 ±  35.72 N/cm2
Trial 3 53.73 ± 32.56 N/cm2
ANOVA summary table for comparison of three
trials of walking on the EMED platform
Source df MS F
Subjects 72 2862.647 9.058699
Trials 2 252.473 .7989
Residual 144 316.007
Intraclass correlation coefficient (3,1) = .7292
APPENDIX G
MASK DEFINITIONS AND FOOT ORIENTATION 
FOR THE EMED SYSTEM MULTIMASK SOFTWARE
The first metatarsal head area is represented by mask 5.















RAW DATA BY GROUPS
H.l. U1MTH. Subject characteristics
GROUP AGE GENDER WT HT TYPE TOUCH VIB INDEX DURAT
1 2 70 F 110 28.0 1 4 39 0.72 24
2 2 55 M 106 29.0 1 4 51 0.96 20
3 2 65 F 65 25.4 2 4 30 1.05 6
4 2 29 F 72 26.8 1 4 51 0.96 16
5 2 64 F 103 25.8 1 4 28 1.18 30
6 2 68 F 73 23.6 1 4 50 0.96 40
7 2 40 M 102 29.5 2 4 51 0.93 3
8 2 55 F 78 26.2 1 4 36 1.09 20
9 2 73 M 92 28.0 1 4 51 1.08 15
10 2 56 M 113 28.4 2 3 51 0.89 14
11 2 59 M 125 29.1 1 4 51 0.75 20
12 2 44 M 64 27.6 1 4 51 0.80 30
13 2 47 F 74 25.4 1 4 51 0.79 38
14 2 74 F 72 24.6 1 4 43 1.17 15
15 2 51 F 86 26.4 2 4 21 1.14 3
16 2 72 M 87 27.8 1 4 51 1.04 20
17 2 66 F 87 26.9 1 3 30 0.81 7
18 2 34 F 88 24.8 1 3 33 1.19 30
19 2 48 F 76 26.6 1 4 34 0.65 42
WT = weight, HT = height,
TOUCH = Semmes Weinstein filaments, VIB = vibration, 
INDEX = ischemic index, DURAT = duration of diabetes
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H.2. U1MTH. First ray mobility and pressure
RAYROM RAYSLOPE PRESSURE P-TIME
1 0,.080 8..83 40,.0 15..0
2 -0 .002 11,.37 94 .0 41,.3
3 0..038 14..99 108,.3 62,.3
4 -0..060 14..96 68..0 22..5
5 0,.185 12..15 102 .7 31 .0
6 0..230 12..04 47..6 16,.7
7 0..070 16.,11 113..0 46..3
8 0..178 12,,11 87..7 33,.3
9 0..265 11..83 77..3 64..7
10 0..035 14..16 58..0 31,.0
11 -0..325 15. 65 110..7 51..7
12 0..418 10..66 59..7 24..3
13 0.,376 10.,85 100..3 38..0
14 0.,437 9..12 92..3 45..3
15 0..353 7..81 106..7 51,.7
16 0.,060 13.,64 95..7 40.,0
17 0.,036 13.,91 51..7 14.,3
18 0,,018 9..93 115..7 48..3
19 -0.,667 10.,16 125..7 47.,0
kAYROM = first ray dorsiflexion, 
RAYSLOPE = first ray slope, 
PRESSURE = peak pressure,
P-TIME = pressure-time integral
H.3. U1MTH. Joint mobility and neutral position
TOEROM ANKLEROM STROM RFNEUTRAL MTNEUTRAL HR0M HIPNEUTRAL
1 45 -3 17 5 0 77 17
2 35 -5 25 11 5 65 25
3 35 5 22 15 5 90 10
4 30 -2 29 15 12 85 -5
5 40 5 22 13 -2 60 0
6 18 5 25 14 3 68 12
7 25 3 24 17 5 83 27
8 60 5 25 13 -2 90 30
9 40 0 18 15 -4 55 20
10 25 10 36 19 -5 90 60
11 40 2 24 22 -5 78 18
12 20 2 18 14 -8 92 32
13 30 8 36 15 -9 59 15
14 70 -1 42 9 -10 90 15
15 37 5 28 15 -5 100 30
16 20 3 13 15 0 67 43
17 35 5 20 12 -5 65 5
18 43 -5 29 12 -5 72 28
19 12 -1 17 7 -16 58 20
TOEROM == first metatarsophalangeal extension,
ANKLEROM = ankle dorsifexion, STROM = subtalar motion, 
RFNEURTRAL = rearfoot neutral, MTNEUTRAL = midtarsal neutral, 
HIPROM = hip motion, HIPNEUTRAL = hip neutral
H.4. U1MTH. Radiographic measurements
RAYLENGTH MTANGLE PRIMUSANGLE
1 9,.35 22,.75 8..50
2 9 .85 15,.00 12,.50
3 8,.60 20.,00 11,.00
4 9,.15 14,,00 12,,50
5 8 .70 17,,00 12,.00
6 8..75 20.,00 10,.00
7 9..30 18,.50 8,,00
8 8,.90 23,,00 8,.00
9 9,.35 17,.50 6,.00
10 9,.50 22.,50 15.,25
11 10,.20 21,,00 13,.50
12 8,.75 23.,50 8.,00
13 8.,50 22.,50 4,,50
14 7,.90 19.,00 14,,00
15 8,.90 20.,50 10..50
16 9,.00 21,,50 8,,50
17 9..25 22.,00 3..50
18 7,,80 22.,00 11.,00
19 9,.00 18.,75 7..50
RAYLENGTH = first ray length, 
MTANGLE = metatarsal declination 
angle,
PRIMUSANGLE = primus varus angle
H.5. UOTHER. Subject characteristics
GROUP AGE GENDER WT HT TYPE TOUCH VIB INDEX DURAT
1 1 66 M 108 29.1 1 4 51 .56 21.0
2 1 65 M 73 26.8 1 4 51 1.09 20.0
3 1 52 F 59 26.0 1 4 51 .84 23.0
4 1 66 F 77 25.6 1 3 40 1.26 31.0
5 1 53 F 78 24.2 2 3 35 1.13 18.0
6 1 60 F 67 26.8 1 4 35 .93 35.0
7 1 52 M 103 29.9 1 4 51 .74 22.0
8 1 66 M 86 28.2 2 3 28 .59 20.0
9 1 59 F 110 24.6 2 3 26 1.20 5.0
10 1 42 M 74 27.6 1 4 51 1.13 27.0
11 1 48 F 82 25.8 1 4 51 1.28 29.0
12 1 69 M 90 26.6 2 4 40 1.00 4.0
13 1 47 F 107 26.0 1 4 32 1.26 15.0
14 1 27 M 103 28.4 1 3 40 1.18 11.0
15 1 37 F 109 25.6 2 3 38 1.08 2.0
16 1 62 M 65 26.8 1 4 51 .71 25.0
17 1 44 M 68 28.2 1 3 21 1.17 4.5
18 1 69 M 90 28.0 1 4 51 1.25 30.0
19 1 51 M 95 28.7 1 4 51 1.00 29.0
20 1 55 F 61 25.2 1 4 45 1.25 35.0
WT = weight, HT = height,
TOUCH = Semmes Weinstein filaments, VIB = vibration,
INDEX = ischemic index, DURAT = duration of diabetes
H.6. UOTHER. First ray mobility and pressure
RAYROM RAYSLOPE PRESSURE P-TIME
1 0..115 12,.86 79..0 29.3
2 -0,.060 13 .68 42..3 15.3
3 0 , 620 12,.88 36..7 11.3
4 0 , 413 10 .00 27..3 8.66
5 0.,825 13,.20 44..3 12.7
6 0 .,530 9,.93 120..0 40.7
7 0 , 420 10,.34 36..0 11.7
8 0 .,540 8,.78 58..3 24.7
9 0 .,598 8,.36 25.,3 6.3
10 0 . 589 9,.56 32.,3 19.0
11 0 .,568 8,.43 34.,7 5.7
12 0.,505 9..13 95..5 35.5
13 0 .,620 12..68 31..7 15.7
14 0 .,497 9..29 22.,7 9.0
15 1 .,078 9,.59 13..0 2.0
16 0 .,510 6..55 19.,0 4.3
17 - 0 .,015 9..62 101. 3 38.3
18 0 .,772 9,.18 77.,0 34.0
19 0 .,468 9.,49 48. 7 16.3
20 0..708 12,.20 44.,3 16.0
RAYROM = first ray dorsiflexion, 
RAYSLOPE = first ray slope, 
PRESSURE = peak pressure,
P-TIME = pressure-time integral
H.7. UOTHER. Joint mobility and neutral position
TOEROM ANKLEROM STROM RFNEUTRAL MTNEUTRAL HROM HIPNEUTRAL
1 15 2 20 16 -2 38 12
2 25 2 22 13 -5 60 40
3 60 5 32 10 5 85 30
4 35 3 27 14 0 53 18
5 45 15 32 2 7 92 52
6 20 0 29 11 -7 70 20
7 23 2 20 8 5 78 42
8 24 5 27 11 0 80 15
9 37 2 22 20 5 80 40
10 47 3 20 13 -5 90 10
11 22 4 10 16 6 65 35
12 32 3 25 18 -5 77 15
13 25 8 23 10 -5 77 22
14 50 5 34 10 5 95 5
15 10 0 27 20 15 105 45
16 20 0 29 18 -7 83 47
17 38 2 22 14 0 97 7
18 35 4 29 14 0 85 25
19 25 3 33 8 5 60 30
20 45 4 32 11 -5 70 0
TOEROM = first metatarsophalangeal extension,
ANKLEROM = ankle dorsifexion, STROM = subtalar motion, 
RFNEURTRAL = rearfoot neutral, MTNEUTRAL = midtarsal neutral, 
HIPROM = hip motion, HIPNEUTRAL = hip neutral
H.8. UOTHER. Radiographic measurements
RAYLENGTH MTANGLE PRIMUSANGLE
1 9 .60 21..75 9,.00
2 9 .40 22 .50 5 .00
3 9 .05 18,.00 7,.00
4 8 .60 15,.00 12,.75
5 8 .35 21..00 5,.50
6 8 .85 18,.00 16 .00
7 9 .25 22..00 3,.50
8 9,.30 24..50 8,.00
9 8,.80 13,.50 13,.50
10 9,.00 22..50 6,.00
11 8..85 16..50 6..00
12 9..00 22..00 11,.00
13 8..40 21..50 9,.50
14 8..95 22..50 7..50
15 8..70 9..50 5,.00
16 8..50 21.,00 8..00
17 9,.60 22..00 7..50
18 9,.00 19..50 13,.50
19 9,.50 24.,00 10..00
20 7..95 22..50 8..50
RAYLENGTH = first ray length, 
MTANGLE = metatarsal declination 
angle,
PRIMUSANGLE = primus varus angle
H.9. DMCONTROL. Subject characteristics
GROUP AGE GENDER WT HT TYPE TOUCH VIB INDEX DURAT
1 5 52 F 89 25.4 1 1 19 .60 5.0
2 5 66 F 59 26.0 1 2 24 .93 12.0
3 5 49 F 79 24.8 1 3 20 .98 20.0
4 5 60 M 104 26.2 2 2 21 .87 3.0
5 5 47 F 114 26.1 2 2 14 .98 5.0
6 5 39 F 101 25.2 2 1 15 .90 .5
7 5 49 F 85 26.4 1 4 51 .94 4.0
8 5 64 F 91 26.5 1 1 6 .97 4.0
9 5 71 F 67 24.6 2 1 17 1.00 14.0
10 5 65 F 115 25.0 1 1 11 .89 15.0
11 5 67 F 96 24.6 1 1 17 .89 15.0
12 5 45 M 126 27.4 2 1 13 1.22 2.5
13 5 28 F 113 27.2 2 1 5 1.04 2.0
14 5 72 M 75 26.8 2 41 .88 1.5
15 5 74 F 73 24.6 1 1 30 1.00 1.0
16 5 39 M 166 28.4 2 1 11 .94 2.0
17 5 55 M 75 27.0 1 2 29 .98 40.0
18 5 57 M 57 24.8 1 1 9 .96 2.0
19 5 72 M 73 26.4 2 4 51 .98 24.0
WT = weight, HT = height,
TOUCH = Semmes Weinstein filaments, VIB = vibration,
INDEX = ischemic index, DURAT = duration of diabetes
.10. DMCONTROL. First ray mobility and pressure
RAYROM RAYSLOPE PRESSURE P-TIME
1 0..686 6 .59 87..0 30,.30
2 0 . 858 8 .61 24,,3 7,.00
3 0 ,.433 10 .39 90..7 14,.30
4 0 ,.740 8 .41 24.,0 9,.00
5 0..697 7,.27 28.,3 8,.30
6 0..437 7 .51 36..0 7,.00
7 0 ,.728 11..35 41,.0 20..30
8 0 . 390 11..92 66..3 22,.67
9 1..110 10,.42 41.,3 19.,33
10 0 . 650 10,.60 28..0 12,.00
11 0 . 865 9,.47 21..3 7..30
12 0 . 660 7..65 36.,7 15..00
13 0 .,840 8..38 30..3 13.,70
14 0 . 575 7,.21 22.,3 8..70
15 0 .,850 6,.87 45..7 11.,70
16 0 .,678 8..30 45. 5 13.,00
17 0 . 527 9..86 35.,3 16..30
18 0..593 9..60 19.,0 7. 30
19 0 . 788 8,.64 22. 3 10. 30
RAYROM = first ray dorsiflexion, 
RAYSLOPE = first ray slope, 
PRESSURE = peak pressure,
P-TIME = pressure-time integral
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H.ll. DMCONTROL. Joint mobility and neutral Postion
TOEROM ANKLEROM STROM RFNEUTRAL MTNEUTRAL HROM HIPNEUTRAL
1 67 6 40 8 -5 75 5
2 35 11 40 13 7 110 20
3 35 0 30 22 15 110 20
4 44 11 32 13 5 87 37
5 45 10 45 8 0 115 35
6 40 6 32 12 0 75 15
7 56 5 27 16 -5 80 10
8 40 3 35 14 0 97 23
9 55 9 37 15 -6 90 10
10 38 2 28 12 4 70 30
11 40 2 24 12 5 100 20
12 58 10 30 8 7 98 62
13 55 2 33 14 -5 90 50
14 50 5 20 15 0 107 42
15 35 7 42 15 0 90 20
16 40 6 35 12 15 90 40
17 47 5 23 13 -10 67 17
18 65 12 36 16 2 97 13
19 45 0 25 12 0 60 40
TOEROM = first metatarsophalangeal extension,
ANKLEROM = ankle dorsifexion, STROM = subtalar motion, 
RFNEURTRAL = rearfoot neutral, MTNEUTRAL = midtarsal neutral, 
HIPROM = hip motion, HIPNEUTRAL = hip neutral
.12. DMCONTROL. Radiographic measurements
RAYLENGTH MTANGLE PRIMUSANGLE
1 8 .70 20..00 10,.00
2 8 .65 21,.50 9 .50
3 8 .95 17..00 14,.00
4 8..95 16.,00 10,.50
5 8 .80 19..50 11..50
6 8,.45 18..75 11,.00
7 8,.30 23..00 7..00
8 9,.40 20..00 7,.25
9 8..35 25..50 8,.00
10 8..40 23..50 16..00
11 8..85 17..50 12,.00
12 8..95 25..50 6,.50
13 8..95 20..00 8..50
14 9..20 23..50 10,.50
15 8..15 16..00 17,.50
16 9..05 20.,00 11..00
17 8,.85 24..50 9..75
18 8..05 22..75 8..50
19 9..55 25..00 7.,00
RAYLENGTH = first ray length, 
MTANGLE = metatarsal declination 
angle,
PRIMUSANGLE — primus varus angle
109
H.13. NCONTROL. Subject characteristics
GROUP AGE GENDER WT HT TYPE TOUCH VIB INDEX DURAT
1 6 65 F 68 26.0 - 1 12 1.23 -
2 6 71 M 73 26.8 - 2 22 1.15 -
3 6 60 M 79 27.2 - 1 11 .95 -
4 6 35 F 86 24.2 - 1 5 1.04 -
5 6 55 F 87 25.5 - 1 9 .98 -
6 6 73 M 104 28.0 - 27 1.10 -
7 6 47 F 79 25.0 - 1 5 .99 -
8 6 66 F 64 24.9 - 1 6 1.03 -
9 6 72 F 85 26.0 - 1 12 1.14 -
10 6 68 F 63 26.8 - 1 7 .93 -
11 6 46 F 67 26.8 - 1 14 1.12 -
12 6 45 M 81 26.8 - 1 9 1.02 -
13 6 41 M 81 28.2 - 1 14 1.13 -
14 6 54 M 93 26.0 - 1 6 .69 -
15 6 50 F 68 25.2 - 1 5 1.06 -
16 6 41 F 76 24.4 - 1 7 1.02 -
17 6 67 F 70 24.8 - 1 24 1.02 -
18 6 73 F 95 25.2 - 1 30 .91 -
19 6 55 M 81 28.0 - 1 13 1.09 -
WT = weight, HT = height,
TOUCH = Semmes Weinstein filaments, VIB = vibration,
INDEX = ischemic index, DURAT = duration of diabetes
.14. NCONTROL. First ray mobility and pressure
RAYROM RAYSLOPE PRESSURE P-TIME
1 0 .505 10,.00 32,.0 9,.67
2 0 ,.070 10..98 83,.0 36..33
3 0 .460 7,.66 47,.0 14 .00
4 0 ,.987 6,.87 22,.0 65,.00
5 0..673 7..68 27..3 8,.33
6 0 ,.915 10,.09 30,.3 12,.67
7 0 . 375 9..04 41,.0 14,.67
8 0 . 950 7..60 27..7 9,.30
9 0..600 14,.90 22,.0 9,.00
10 0 . 967 8..69 49,.3 16,.33
11 0 . 758 8..17 16.,3 8..67
12 0 . 940 8..32 28.,7 12..33
13 0 . 633 10..26 35..7 13,.33
14 0..453 10..08 54..3 17..00
15 0 . 738 9..55 30..3 9..67
16 0 . 750 9..82 28..7 11..33
17 0 . 176 10,.82 90..3 37.,00
18 0..508 9..18 76.,0 27..70
19 0 . 620 14..16 31,.0 9,.30
RAYROM = first ray dorsiflexion, 
RAYSLOPE = first ray slope, 
PRESSURE = peak pressure,
P-TIME = pressure-time integral
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H.15. NCONTROL. Joint mobility and neutral position
TOEROM ANKLEROM STROM RFNEUTRAL MTNEUTRAL HROM HIPNEUTRAL
1 50 4 25 16 -7 85 35
2 27 3 20 14 0 90 20
3 55 10 35 11 -7 100 30
4 65 16 42 12 5 110 20
5 28 5 30 19 0 75 5
6 37 9 26 13 0 92 12
7 45 0 32 23 0 95 15
8 57 5 33 13 5 107 17
9 50 6 30 12 8 82 2
10 45 0 25 5 5 78 8
11 56 6 45 13 15 103 13
12 40 5 27 14 2 92 16
13 50 6 31 14 5 110 0
14 50 5 26 13 -5 85 15
15 52 10 36 16 0 102 32
16 63 12 40 9 -3 105 15
17 56 -2 37 13 0 102 22
18 40 7 28 18 5 95 15
19 30 5 34 5 3 82 8
TOEROM = first metatarsophalangeal extension,
ANKLEROM = ankle dorsifexion, STROM = subtalar motion, 
RFNEURTRAL = rearfoot neutral, MTNEUTRAL = midtarsal neutral, 
HIPROM = hip motion, HIPNEUTRAL = hip neutral
.16. NCONTROL. Radiographic measurements
RAYLENGTH MTANGLE PRIMUSANGLE
1 8 .35 21 .00 8 .50
2 9 .50 22,.75 7 .00
3 9 .30 23,.75 7,.50
4 8,.05 16,.00 13,.75
5 8 .95 19,.00 10,.50
6 9,.20 25,.00 11..50
7 8..55 17..00 10,.25
8 8..65 22..00 12..50
9 8..65 26,.00 6..50
10 8..90 27..00 15..00
11 9,.05 23..00 13,.00
12 8.,80 18.,00 11..00
13 9.,10 20. 00 8.,50
14 9..45 23. 50 10.,50
15 8.,60 15.,50 10.,00
16 8. 20 23. 00 6. 50
17 8. 65 21. 00 9. 00
18 8.,85 20. 00 16.,00
19 9. 55 23. 75 8. 00
RAYLENGTH = first ray length, 
MTANGLE = metatarsal declination 
angle,
PRIMUSANGLE = primus varus angle
APPENDIX I
MEANS, STANDARD DEVIATIONS AND RANGES 
FOR RESPONSE VARIABLES BY GROUPS
1.1. U1MTH
variable n mean SD range
Age (years) 19 56.30 13.40 29.0 - 74.0
Weight (kg) 19 88.10 17.60 63.5 - 124.7
Height (cm) 19 26.80 1.70 23.6 - 29.5
TOUCH (filament number) 19 3.80 0.40 3 - 4
VIBRATION (volts) 19 42.30 10.30 21 - 51
INDEX (ratio) 19 0.96 0.17 0.65 - 1.19
DURATION (years) 19 20.70 11.90 3.0 - 42.0
RAYROM (degrees) 19 0.09 0.26 -0.67 - 0.44
RAYSLOPE (kg/cm slope) 19 12.10 2.40 7.8 - 16.1
PRESSURE (N/cm2) 19 87.10 25.80 40.0 - 125.7
PRESSURE-TIME (N-s/cm2) 19 38.10 15.10 14.3 - 64.7
TOEROM (degrees) 19 34.70 14.20 12.0 - 70.0
ANKLEROM (degrees) 19 2.20 4.20 -5.0 - 10.0
STROM (degrees) 19 24.70 7.40 13.0 - 42.0
HIPROM (degrees) 19 76.00 13.90 55.0 - 100.0
RFNEUTRAL (degrees) 19 13.60 3.90 5.0 - 22.0
MTNEUTRAL (degrees) 19 3.20 5.20 -6.0 - 15.0
HIPNEUTRAL (degrees) 19 21.20 15.00 -5.0 - 60.0
RAYLENGTH (cm) 19 9.00 0.60 7.8 - 10.2
MTANGLE (degrees) 19 20.10 2.70 14.0 - 23.5




variable n mean SD range
Age (years) 20 54.50 11.40 27.0 - 69.0
Weight (kg) 20 85.30 17.30 58.5 - 109.8
Height (cm) 20 26.90 1.60 24.2 - 29.9
TOUCH (filament number) 20 3.70 .50 3 - 4
VIBRATION (volts) 20 41.90 9.90 21 - 51
INDEX (ratio) 20 1.03 .23 .56 - 1.28
DURATION (years) 20 20.30 10.50 2.0 - 35.0
RAYROM (degrees) 20 0.51 0.27 -0.06 - 1.08
RAYSLOPE (kg/cm slope) 20 10.29 1.95 6.55 - 13.68
PRESSURE (N/cm2) 20 49.50 29.80 13.0 - 120.0
PRESSURE-TIME (N-s/cm2) 20 17.80 11.90 2.0 - 40.71
TOEROM (degrees) 20 31.60 13.00 10.0 - 60.0
ANKLEROM (degrees) 20 3.60 3.30 0.0 - 15.0
STROM (degrees) 20 25.70 5.90 10.0 - 34.0
HIPROM (degrees) 20 77.00 16.20 38.0 - 105.0
RFNEUTRAL (degrees) 20 12.80 4.50 2.0 - 20.0
MTNEUTRAL (degrees) 20 3.20 5.20 -7.0 - 15.0
HIPNEUTRAL (degrees) 20 25.50 15.40 0.0 - 52.0
RAYLENGTH (cm) 20 8.90 0.40 7.9 - 9.6
MTANGLE (degrees) 20 20.00 3.80 9.5 - 24.5
PRIMUSANGLE (degrees) 20 8.60 3.30 3.5 - 16.0
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1.3. DMCONTROL
variable n mean SD range
Age (years) 19 56.40 13.20 28.0 - 74.0
Weight (kg) 19 92.60 26.70 56.7 - 166.5
Height (cm) 19 25.90 1.10 24.6 - 28.4
TOUCH (filament number) 19 1.70 1.00 1 - 4
VIBRATION (volts) 19 21.30 13.70 5.0 - 51.0
INDEX (ratio) 19 0.94 0.11 0.60 - 1.22
DURATION (years) 19 10.90 13.10 0.5 - 44.0
RAYROM (degrees) 19 0.69 0.18 0.39 - 1.11
RAYSLOPE (kg/cm slope) 19 8.90 1.56 6.59 - 11.92
PRESSURE (N/cm2) 19 39.20 20.90 19.0 - 90.7
PRESSURE-TIME (N-s/cm2) 19 13.30 6.30 7.0 - 30.3
TOEROM (degrees) 19 46.80 10.10 35.0 - 67.0
ANKLEROM (degrees) 19 5.90 3.80 0.0 - 12.0
STROM (degrees) 19 32.30 6.80 21.0 - 45.0
HIPROM (degrees) 19 89.90 15.60 60.0 - 115.0
RFNEUTRAL (degrees) 19 13.20 3.30 8.0 - 22.0
MTNEUTRAL (degrees) 19 4.10 5.40 -6.0 - 15.0
HIPROM (degrees) 19 26.80 15.30 5.0 - 62.0
RAYLENGTH (cm) 19 8.70 0.40 8.0 - 9.5
MTANGLE (degrees) 19 21.00 3.10 16.0 - 25.5
PRIMUSANGLE (degrees) 19 10.30 3.00 6.5 - 17.5
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1.4. NCONTROL
variable n mean SD range
Age (years) 19 57.10 12.30 35.0 - 73.0
Weight (kg) 19 79.00 11.20 62.6 - 103.9
Height (cm) 19 26.10 1.20 24.2 - 28.2
TOUCH (filament number) 19 1.10 0.30 1 - 2
VIBRATION (volts) 19 12.50 7.80 5.0 - 30.0
INDEX (ratio) 19 1.03 0.12 0.69 - 1.23
DURATION (years) --
RAYROM (degrees) 19 0.64 0.26 0.07 - 0.99
RAYSLOPE (kg/cm slope) 19 9.68 2.07 6.87 - 14.90
PRESSURE (N/cm2) 19 40.70 21.30 16.3 - 90.3
PRESSURE-TIME (N-s/cm2) 19 15.10 8.80 8.3 - 37.0
TOEROM (degrees) 19 47.10 11.10 27.0 - 65.0
ANKLEROM (degrees) 19 5.90 4.30 -2.0 - 16.0
STROM (degrees) 19 31.70 6.50 20.0 - 45.0
HIPROM (degrees) 19 94.20 10.90 75.0 - 110.0
RFNEUTRAL (degrees) 19 13.30 4.20 5.0 - 22.5
MTNEUTRAL (degrees) 19 3.70 3.90 0.0 - 15.0
HIPNEUTRAL (degrees) 19 15.80 9.50 0.0 - 35.0
RAYLENGTH (cm) 19 8.90 0.40 8.0 - 9.6
MTANGLE (degrees) 19 21.40 3.30 15.5 - 27.0
PRIMUSANGLE (degrees) 19 10.30 2.80 6.5 - 16.0
APPENDIX J
ANALYSIS OF VARIANCE FOR RESPONSE VARIABLES
J.l. First ray dorsiflexion
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 4.1983 1.3994 23.24 0.0001
Error 73 4.3952 0.0602
Total 76 8.5935
J.2. First ray slope
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 107.4609 35.8203 8.75 0.0001
Error 73 298.7377 4.0923
Total 76 406.1986
J.3. Peak pressure
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 28758.4948 9586.1649 15.60 0.0001
Error 73 44848.6883 614.3656
Total 76 73607.1831
J.4. Pressure-time integral
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 7563.6148 2521.2049 20.69 0.0001





Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 70.409 23.4698 0.15 0.9308
Error 73 11590.4736 158.7736
Total 76 11660.8831
J.6. Weight
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 9014.7501 3004.9167 1.71 0.1716
Error 73 127963.2368 1752.92101
Total 76 136977.9871
J.7. Height
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 88.8978 29.6326 2.35 0.0797
Error 73 921.8273 12.6277
Total 76 1010.7251
J .8. Touch sensation
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 109.7302 36.5767 99.00 0.0001
Error 73 26.9711 0.3695
Total 76 136.7013
J.9. Vibration sensation
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 12956.1655 4318.7218 38.39 0.0001
Error 73 8213.0552 112.5076
Total 76 21169.2208
J .10. Ischemic index
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 0.1299 0.0433 1.59 0.2001
Error 73 1.9933 0.0273
Total 76 2.1233
J .11. Duration of diabetes
Source DF Sum of Squares Mean Square F ratio Probability
Groups 2 1167.0900 583.5450 4.15 0.0209
Error 55 7731.1901 140.5671
Total 57 8898.2802
J. 12. First metatarsophalangeal <extension













J .13. Ankle dorsiflexion













J .14. Subtalar range of motion














J.15. Hip range of motion
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 4834.5072 1611.5024 7.86 0.0001
Error 73 14968.9474 205.0541
Total 76 19803.4545
J.16. Rearfoot neutral
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 5.3485 1.7828 0.11 0.9531
Error 73 1166.3658 15.9776
Total 76 1171.7142
J.17. Midtarsal neutral
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 11.1554 3.7184 0.15 0.9282
Error 73 1787.8316 24.4908
Total 76 1798.9870
J.18. Hip neutral
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 1417.6904 472.3635 2.40 0.0751
Error 73 14399.8421 197.2581
Total 76 15817.5325
J .19. First ray length
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 0.5233 0.1744 0.79 0.5018
Error 73 16.0587 0.2200
Total 76 16.5820
J.20. Metatarsal declination angle
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 29.8492 9.9497 0.93 0.4322
Error 73 783.5988 10.7342
Total 76 813.4481
J . 21. Primus varus angle
Source DF Sum of Squares Mean Square F ratio Probability
Groups 3 36.3384 12.1128 1.27 0.2917
Error 73 697.3094 9.5522
Total 76 733.6477
APPENDIX K
CHI-SQUARE TABLES AND ANALYSIS OF GROUP DIFFERENCES 
FOR CATEGORICAL RESPONSE VARIABLES
K.l. Type Diabetes
Group Type I Type II Total
UlMTH 4 15 19
UOTHER 5 15 20
DMCONTROL 9 10 19
Total 18 40 58
Chi-square = 3.58, (p > 0.05)
K.l. Gender
Group Male Female Total
UlMTH 7 12 19
UOTHER 11 9 20
DMCONTROL 7 12 19
NCONTROL 7 12 19
Total 32 45 77
Chi-square =2.01, (p > 0.05)
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